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CHAPTER I 
 
INTRODUCTION 
 
The mechanism of pre-mRNA splicing 
Most eukaryotic genes are transcribed into pre-mRNA containing coding sequences 
(exons) disrupted by intervening sequences (introns).  Prior to translation, the introns 
must be efficiently and accurately removed and the exons joined together in a process 
known as pre-mRNA splicing (Burge et al., 1999; Hastings and Krainer, 2001).  It is 
very important to maintain the fidelity of pre-mRNA splicing, an error as small as a 
single nucleotide can completely shift the reading frame leading to the production of 
truncated proteins. 
To define an intron, three cis-acting elements are required: the 5’splice site, the 3’ 
splice site, and the branch point/polypyrimidine-tract just upstream of the 3’ splice site.  
The 5’ and 3’ splice sites define the exon/intron boundaries while the branch point 
provides an adenosine for nucleophilic attack on the 5’ splice site.  Splicing occurs in 
two sequential transesterification reactions, the first of which involves cleavage of the 5’ 
exon and attack of the 5’ splice site by the branch point adenosine, generating a lariat 
intron-3’ exon intermediate.  The second step ligates the exons together and releases the 
lariat intron (Fig. 1). 
Although the basic chemistry of splicing is extremely conserved and quite 
straightforward, splicing is indeed a very complicated task, given the small size of the 
cis-elements (splice sites and the branch point) and the size of the eukaryotic genome. 
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Figure 1.  Two catalytic steps of pre-mRNA splicing.  Diagram of two exons and the 
intervening intron.  The consensus sequences for higher eukaryotic 5’ splice site (5’ SS), 
3’splice site (3’ SS), branch point (BP) and the polypyrimidine-tract (Py) are indicated (N 
= any nucleotide, Y = pyrimidine, R = purine).  The two sequential transesterification 
steps are shown.  
 
A Py AG
A Py AG
A Py AG
Py YAGAGGURAGU
5’ SS
YNCURAY
Exon2Exon1
3’ SSBP
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The process is simplified somewhat in lower eukaryotes such as S. cerevisiae where 
introns are generally small and the cis-elements are highly conserved.  However, in 
higher eukaryotes, the typical length of an intron can be as large as 200,000 nucleotides 
(nt) while the average size for an exon is less than 200 nt (Berget, 1995).  Furthermore, 
splice site sequences in higher eukaryotes are not highly conserved (see Fig. 1), making it 
even more difficult for precise exon/intron definition.  Given these constraints, the 
accuracy of splicing is quite amazing. 
Splicing is carried out within a large complex referred to as the spliceosome.  The 
spliceosome is composed of five small nuclear ribonucleoprotein particles (U1, U2, 
U4/U6, and U5 snRNPs; Lührmann, 1988) and other non-snRNP protein factors 
(reviewed in Jurica and Moore, 2003).  Each snRNP contains one or two specific small 
nuclear RNAs (snRNA) bound by several protein factors that play important roles in both 
spliceosome assembly and the two catalytic steps of splicing.  Dynamic base pairing 
interactions between the snRNAs and the pre-mRNA and between the snRNAs 
themselves are crucial for accurate definition of the exon/intron boundaries (Nilsen, 
1998).  U1 snRNA base pairs with the 5’ splice site while U2 pairs with the branch point.  
Upon association with U4/U6.U5, a series of rearrangements occur, including 
dissociation of U1 from the 5’ splice site and dissociation of U4 from U6, allowing 
different regions of U6 to pair with both the 5’ splice site and with U2 snRNA.  During 
these changes, U5 appears to play an important role in tethering the two exons to 
juxtapose them for catalysis (Alvi et al., 2001; McConnell and Steitz, 2001; Newman, 
1997; O'Keefe and Newman, 1998; also see Fig. 2 and spliceosome assembly below). 
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To ensure the accuracy of splicing, these RNA rearrangements take place in a 
highly ordered and well regulated manner (Reed, 2000).  Although the mechanism of 
this is not completely understood, two groups of protein factors are thought to be 
involved.  One contains members of a superfamily of ATPases, including the DEAD 
and DEAH box families.  These ATPases are proposed to facilitate RNA 
rearrangements by unwinding RNA duplexes or by disrupting RNA-protein interactions 
(Staley and Guthrie, 1998).  The second group of factors represents members of a family 
of RNA binding proteins containing RNA recognition motifs (RRMs; Burd and Dreyfuss, 
1994; Swanson, 1995).  The RRMs of these proteins are thought to mediate binding to 
single-stranded RNA, but RRMs also participate in protein-protein interactions, allowing 
this group of factors to play distinct roles in annealing critical RNA-RNA pairs, 
stabilizing single-stranded RNAs, and facilitating exon/intron definition (Fu, 1995; Ghetti 
et al., 1995; Valcárcel et al., 1996). 
 
Spliceosome Assembly 
During the past twenty years, many efforts have been dedicated to understand the 
assembly and composition of the spliceosome.  Based on studies using cell extracts and 
in vitro splicing, most of the current models of spliceosome formation suggest a stepwise 
assembly pathway that requires ATP and substrate pre-mRNAs.  The process begins 
with recognition of the 5’ splice site by U1 snRNP and the polypyrimidine-tract by the 
U2 snRNP auxiliary factor (U2AF) heterodimer, initiating the formation of an 
ATP-independent, discrete early complex (E complex).  Binding of U2AF to the 
polypyrimidine-tract recruits U2 snRNP to the branch point sequence, forming complex 
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Figure 2.  Models for spliceosome assembly.  (A) The model adapted from Weaver 
(1999) showing the spliceosome cycle (stepwise assembly of the spliceosome complexes 
and recycling of snRNPs for the next round of splicing).  (B) The model adapted from 
Stevens et al. (2002) showing the yeast penta-snRNP assembled onto the pre-mRNA 
substrate as a pre-formed particle. 
 
A
B
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A.  The B complex is then formed when the U4/U6.U5 tri-snRNP joins the complex.  
A series of dynamic RNA/protein rearrangements then converts the B complex to the C 
complex, the short-lived, active spliceosome (reviewed in Reed and Palandjian, 1997; Fig. 
2A).  These short-lived spliceosomal complexes can be distinguished by their snRNP 
composition and different mobilities in native gels. 
Over the years, these individual complexes have been purified and their contents 
analyzed by different strategies (reviewed in Jurica and Moore, 2003).  The common 
theme linking these studies has been the demonstration that the spliceosome is a dynamic 
entity.  However, to what extent this model reflects the in vivo situation is not entirely 
clear.  In 2002, two different endogenous complexes were isolated from yeast.  One of 
them, the Cwf/Cwc complex was purified from both S. cerevisiae and S. pombe (Ohi et 
al., 2002).  Although it is very similar to the in vitro-assembled mammalian C complex 
(Jurica et al., 2002) in both structure and contents (U2, U5, U6 snRNPs as well as other 
second step splicing factors), the fact that the Cwf complex remains stable in 
splicing-deficient strains questions its functional relevance.  Nevertheless, the 
identification of this complex raises the question as to whether spliceosomes might also 
exist as larger pre-formed complexes.  Consistent with this possibility was the discovery 
of a 45S penta-snRNP from S. cerevisiae which contains all of the five splicing snRNPs 
and over 60 pre-mRNA splicing factors.   Strikingly, the penta-snRNP is capable of 
splicing when supplied with micrococcal nuclease treated nuclear extracts and therefore 
functions as a pre-formed particle (Stevens et al., 2002).  Thus, at least in the yeast S. 
cerevisiae there may be preformed spliceosomes rather than stepwise assembly on 
demand (Fig. 2B).  In this view, in vitro assembly intermediate complexes may just 
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reflect multiple dynamic conformational changes during maturation of largely pre-formed 
spliceosomes (Nilsen, 2003).  It remains unclear whether pre-formed spliceosomes are 
limited to yeast since no such particles have been purified from mammalian extracts. 
 
The composition of the spliceosome 
Despite the two perhaps contradictory models of spliceosome assembly, it has been 
agreed for years that the spliceosome is a large, complicated particle (Moore et al., 1993).  
Early experiments in both mammalian and yeast systems identified the five U snRNPs 
and a variety of other proteins as essential splicing factors.  Recent powerful 
combinations of affinity purification coupled to large-scale protein identification by mass 
spectrometry has led to a fairly comprehensive proteomic analyses of different 
spliceosomal complexes, providing a much broader view of the spliceosome.  Currently, 
the list of spliceosome proteins has expanded to nearly 300 candidate proteins with the 
challenge to determine the function of individual components. 
Eighteen different spliceosomal complexes purified by different groups have been 
reported, and their core components can be assorted into six groups (Table 1; reviewed in 
Jurica and Moore, 2003).  The first group is snRNP related proteins, including the Sm 
proteins and proteins specific to U1, U2, U4/U6, and U5 snRNPs.  The second group is 
a group of miscellaneous splicing factors, most of which have been known for years as 
spliceosomal components and essential for splicing.  These include Splicing Factor 1 
(SF1), U2AF65, U2AF35, cap binding proteins (CBP), and second step factors. 
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Table 1.  Proteins identified in purified spliceosomal complexes.  Derived from 
Jurica and Moore (2003).  Proteins identified in any of the following complexes are 
indicated (●): M: mixed spliceosome complexes assembled in vitro from human nuclear 
extract (Neubauer et al., 1998; Rappsilber et al., 2002; Zhou et al., 2002); A, B*, C: in 
vitro assembled A complex (Hartmuth et al., 2002), B* complex (Makarov et al., 2002), 
C complex (Jurica et al., 2002) from human nuclear extract, respectively; Cw: 
endogenous Cwf/Cwc complex from S. cerevisiae and S. pombe (Ohi et al., 2002); P: 
endogenous penta-snRNP from S. cerevisiae (Stevens et al., 2002); 35S: 35S U5 snRNP 
from human extracts (Makarov et al., 2002); U2: 12S U2 snRNP from human nuclear 
extracts (Will et al., 2002); Tri: U4/U6.U5 tri-snRNP from S. cerevisiae (Gottschalk et 
al., 1999; Stevens and Abelson, 1999); H: H complex assembled in vitro from human 
nuclear extracts (Jurica et al., 2002); TAP: splicing factor containing complexes from S. 
cerevisiae (Gavin et al., 2002), supplemental data S3, complexes 128, 129, 155, 158, 160, 
and 161).  Proteins found in 1-2 out of the 6 TAP complexes are marked with(○). 
 
Human Name S.cerevisiae Name M A B* C Cw P 35S U2 Tri H TAP 
Core snRNP proteins                       
SmB/B' Smb1 ● ● ● ● ● ● ● ● ● ● ● 
SmD1 Smd1 ● ● ● ● ● ● ● ● ●  ● 
SmD2 Smd2 ● ● ● ● ● ● ● ● ●  ● 
SmD3 Smd3 ● ● ● ● ● ● ● ● ● ● ● 
SmE1 Sme1 ● ● ● ●  ● ● ● ●   
SmF1 Smf1 ● ● ● ● ● ● ● ● ●  ○ 
SmG1 Smx2 ● ● ● ● ● ● ● ● ●   
LSM2 Lsm2 ●  ● ●  ●   ●  ○ 
LSM3 Lsm3 ●  ● ●  ●     ○ 
LSM4 Lsm4 ●     ●   ●  ● 
LSM5 Lsm5         ●  ○ 
LSM6 Lsm6 ●     ●   ●  ○ 
LSM7 Lsm7 ●     ●   ●  ○ 
LSM8 Lsm8 ●     ●   ●   
             
U1 snRNP specific proteins                     
U1 70kD Snp1 ● ●       ●         ● 
U1 A Mud1 ● ●    ●    ● ● 
U1 C Yhc1 ● ●    ●     ● 
 Prp39      ●     ● 
FBP11 Prp40 ●     ●     ● 
 Snu56      ●     ● 
 Nam8      ●     ○ 
 Snu71      ●     ● 
 Snu65      ●     ● 
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Table 1, continued             
Human Name S.cerevisiae Name M A B* C Cw P 35S U2 Tri H TAP 
U2 snRNP specific proteins                     
U2 A' Lea1 ● ● ● ● ● ●   ●   ● ● 
U2 B'' Msl1 ● ● ● ● ● ●  ●   ● 
SF3a60 Prp9 ● ● ● ● ● ●  ●  ● ● 
SF3a66 Prp11 ● ● ● ● ● ●  ●   ● 
SF3a120 Prp21 ● ● ● ● ● ●  ●  ● ● 
SF3b49 Hsh49 ● ● ● ● ● ●  ●   ○ 
SF3b145 Cus1 ● ● ● ● ● ●  ●  ● ● 
SF3b130 Rse1 ● ● ● ● ● ●  ●  ● ● 
SF3b155 Hsh155 ● ● ● ● ● ●  ●  ● ● 
SF3b10  ● ● ●     ●    
SF3b14b Rds3p ● ● ●     ●    
p14 Snu17 ● ● ●   ●  ●    
             
U5 snRNP specific proteins                     
PRP8 Prp8 ● ● ● ● ● ● ●   ● ● ● 
U5-200kDa Brr2 ● ● ● ● ● ● ●  ● ●  
U5-116kDa Snu114 ● ● ● ● ● ● ●  ● ● ● 
U5-102kDa Prp6 ● ● ● ●  ●   ● ● ● 
U5-100kDa Prp28 ● ●  ●      ● ○ 
U5-40kDa  ●  ● ● ●  ●   ●  
U5-15kDa Dib1 ●     ●   ●  ● 
             
U4/U6 snRNP specific proteins                     
HPRP3 Prp3 ●         ●     ●   ● 
HPRP4 Prp4 ●   ●  ●   ●  ● 
RY-1  ●           
USA-Cyp Cpr1 ●           
15.5tri-snRNP Snu13 ●     ●   ●   
                          
Miscellaneous splicing factors                     
U2AF65 Mud2 ● ●           ●   ●   
U2AF35  ● ●      ●    
SF1 Msl5 ●           
CBP20 Cbc2 ● ● ● ●       ○ 
CBP80 Sto1 ● ● ● ●      ● ● 
PRP31 Prp31 ●     ●   ●  ● 
 Snt309     ● ●     ● 
PRP17 Prp17 ●   ● ●  ●    ○ 
SLU7 Slu7 ●   ● ●      ○ 
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Table 1, continued             
Human Name S.cerevisiae Name M A B* C Cw P 35S U2 Tri H TAP 
PRP18 Prp18           ○ 
PSF  ●  ●       ●  
 Prp38      ●   ●  ○ 
PRP24 Prp24           ○ 
DDX3 Ded1 ●     ●      
 Npl3      ●     ○ 
SKIP Prp45 (Cwf13) ●  ● ● ● ● ●   ● ○ 
ECM2 Ecm2 (Cwf5) ●  ● ● ● ● ●   ● ● 
SART1 Snu66 ● ● ● ●  ●   ●  ● 
p68 Dbp2 ● ● ● ●      ●  
SPF30  ● ●      ●    
FLJ31121 Snu23   ●   ●   ●  ○ 
SAD1 Sad1 ●     ●      
LUC7 Luc7 (Luc7) ●     ●     ● 
 Spp381      ●   ●   
PUF60  ●   ●    ●  ●  
PRP4 kinase ●           
                          
Proteins containing a DEAD/H box motif (RNA unwindases)         
DDX16 Prp2 ●   ●       ○ 
PRP5 Prp5 ● ●      ●    
PRP16 Prp16 ●   ●        
PRP22 Prp22 ●  ● ● ●      ○ 
PRP43 Prp43 ● ● ● ●    ●  ● ● 
UAP56 Sub2 ●          ● 
HDB/DICE1 ●  ●         
Abstrakt  ●   ●        
eIF4a3  ●  ● ●        
DDX35     ●   ●     
DDX9  ● ●          
KIAA0052  ●   ●      ●  
p72  ●   ●      ●  
                          
Proteins associated with the Prp19 complex          
CDC5 Cef1 (Cdc5) ●   ● ● ● ● ●     ● ○ 
PRP19 Prp19 ● ●  ● ● ● ●   ● ● 
ISY1 Isy1 (Cwf12) ●  ● ● ● ● ●   ● ○ 
SYF1 Syf1 (Cwf3) ●  ● ● ● ● ●    ○ 
CRN Clf1 (Cwf4) ●  ● ● ● ● ●    ● 
GCIP-IP Syf2(C3E7.13C) ●  ● ● ● ● ●     
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Table 1, continued             
Human Name S.cerevisiae Name M A B* C Cw P 35S U2 Tri H TAP 
PRL1 Prp46 (Cwf1) ●  ● ● ● ● ●   ● ● 
BCAS2 (Cwf7) ●  ●  ●  ●     
 Ntc20     ● ●      
 Cwc2 (Cwf2)    ● ●     ● 
                          
Auxiliary splicing factors                     
SPF45  ● ●      ●    
PTB  ●         ●  
EWS  ●   ●        
             
SR proteins                       
SRm300   ●     ●               
SRm160  ●   ●        
SC35  ● ●          
SRp40  ● ●          
SRp55  ● ●          
SRp75  ●   ●        
SRp30c  ● ● ●         
9G8  ● ● ● ●        
SRp54  ●           
SFRS10  ●   ●        
SRp20  ● ● ●         
ASF/SF2  ● ●  ●    ●    
                          
Proteins with roles in RNA metabolism processes linked to splicing        
Aly/REF Yra1 ● ● ● ●           ●   
RNPS1  ●   ●      ●  
Y14  ●   ●        
MAGOH  ●   ●        
hTHO2 Rlr1 ●           
hHPR1  ●   ●      ●  
HsKin17 Rts2p ●  ●         
ASR2B  ● ●          
KIAA0983  ●           
C21orf66  ●           
PAB2  ●  ● ●      ●  
CF I-68kD  ●           
CF I-25kD  ●           
CPSF 160K ●  ●         
Tat-SF1 Cus2 ●         ●           
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The third group belongs to a superfamily of ATPases, consisting of DEAD/H box 
proteins, some of which are known RNA unwindases.  In yeast, eight such proteins 
(Prp2p, Prp16p, Prp22p, Prp43p, Brr2p, Prp5p, Prp28p, and Sub2p) have been shown to 
function in pre-mRNA splicing, and each one of them is currently linked to a specific 
ATP-driven structural transition step in the splicing cycle (reviewed in Staley and Guthrie, 
1998).  For example, Prp28/U5-100kDa has been suggested to disassociate U1 from the 
5’ splice site (Chen et al., 2001; Staley and Guthrie, 1999).  Interestingly, several 
DEAD/H proteins have been identified in mammalian spliceosomal complexes that are 
unrelated to yeast proteins suggesting additional complexity in mammals (Jurica and 
Moore, 2003). 
The fourth group of proteins represents members of the Prp19 complex (NTC; Chan 
et al., 2003; Chen et al., 2002; Ohi and Gould, 2002; Tarn et al., 1994), most of which 
have been shown to be required for splicing by genetic and functional analysis.  In yeast, 
the NTC complex joins the spliceosome subsequent to U4 snRNP dissociation, and is 
required for stable association of U5 and U6 with the activated spliceosome (Chan et al., 
2003).  In mammals, hPrp19 was found to associate with CDC5 in a similar complex 
(Ajuh et al., 2000), and this CDC5/Prp19 complex has been implicated to function after 
joining of the U4/U6.U5 tri-snRNP but prior to or during the first and second catalytic 
steps of splicing (Ajuh et al., 2000; Makarov et al., 2002). 
The fifth group consists of auxiliary splicing factors which function to facilitate 
recognition of non-conserved splice sites by the splicing machinery.  The best 
characterized of these factors are the SR protein family (reviewed in Cáceres et al., 1997; 
Fu, 1995; Gravely, 2000).  The presence of these proteins in purified spliceosomal 
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complexes varies from substrate to substrate and also depends on the particular 
purification strategy, probably due to loose association with other spliceosome 
components. 
The last group, which might not participate in pre-mRNA splicing directly, is 
composed of protein factors involved in other nuclear functions, such as mRNA 
3’-processing factors (cleavage factor I, CF I; cleavage and polyadenylation specificity 
factor, CPSF 160), components of exon junction complex (EJC), and the 
transcription/export (TREX) complex.  The TREX complex has been proposed to link 
transcription elongation to mRNA export (Reed and Cheng, 2005; Strasser et al., 2002), 
while the EJC complex functions in mRNA export and nonsense mediated decay (NMD) 
(Le Hir et al., 2001; Maquat, 2005).  The association of these proteins with the 
spliceosome provides further evidence supporting the functional coupling between 
splicing and other nuclear mRNA processing events (Maniatis and Reed, 2002; Reed, 
2003). 
 
Alternative splicing 
As noted above, splicing is a complicated process, involving multiple RNA and 
protein factors.  Besides the complexity caused by long introns and weakly conserved 
splice sites, the presence of more than one intron in a given gene creates an even more 
complicated situation.  The splicing machinery does not always remove all introns to 
generate mature mRNA (constitutive splicing).  Instead, splicing and splice site choice 
are often highly regulated.  Alternative splicing generates different mRNAs encoding 
distinct protein products from a single gene, greatly increasing protein diversity from a 
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more limited genome (Patton and Smith, 2001; Smith and Valcarcel, 2000).  Originally 
considered a rare event, the completion of human genome and recent application of 
bioinformatic tools have revealed that up to 74% of human genes are alternatively spliced 
(Johnson et al., 2003).  In addition to protein diversity, alternative splicing also 
functions in the regulation of gene expression.  When coupled with NMD, around 
18-25% of the alternatively spliced exons are predicted to regulate transcript abundance 
(reviewed in Stamm et al., 2005). 
Alternative splicing is regulated through the combinatorial interplay of variable 
strength cis-acting elements and the binding of trans-acting proteins (reviewed in Matlin 
et al., 2005; Smith and Valcarcel, 2000).  Because the splice site sequences are not 
highly conserved, a variety of other elements have been identified that help define intron 
and exon boundaries.  The best characterized of these cis-acting regulatory elements are 
referred to as splicing enhancers and silencers.  They are recognized by different 
alternative splicing factors (usually hnRNPs and SR proteins), which in turn facilitate or 
inhibit the recruitment of splicing machinery to a particular splice site.  In many cases, 
the regulation of alternative splicing is not just direct promoting or inhibiting the usage of 
one splice site by individual regulators, but a combinatorial effect of multiple interactions 
between positive and negative regulators with enhancers and silencers.  Thus, the cell- 
or tissue-specific regulation of splicing is usually controlled by the overall ratio of 
different alternative splicing factors present, not simply depends on the amount of one 
particular factor. 
Many tissue-specific protein isoforms that result from alternative splicing have been 
identified (Fig. 3).  One good example of tissue-specific alternative splicing is the  
 15
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Patterns of alternative splicing.  Constitutive and alternative exons are 
represented by dark and light grey boxes, respectively.  Introns are represented by 
straight lines.  Five basic patterns of alternative splicing are shown.  The simplest ones 
are the retention of an intron and the skipping or inclusion of an exon.  The third one 
represents a pair (or a set) of exons that are never spliced together (mutually exclusive), 
while the last two involves joining of one splice site to one of the several possible splice 
sites (alternative 5’ and 3’ splice sites). 
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Alternative 3’ splice sites
Alternative 5’ splice sites
Mutually exclusive exons
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splicing of α- tropomyosin (α-TM), exons 2 and 3, a pair of mutually exclusive exons 
(Fig. 4).  In most cell types, and focusing on just the first four exons of α-TM, exons 
1-3-4 are spliced together while in smooth muscle cells, exons 1-2-4 are joined (Smith 
and Nadal-Ginard, 1989).  Inclusion of exon 2 involves multiple cis-acting elements and 
splicing factors, including repression of exon 3 by polypyrimidine tract-binding protein 
(PTB) and Raver1 (Gromak et al., 2003) and activation of exon 2 by the SR protein 9G8 
through an exonic splicing enhancer (ESE) (our lab, unpublished data). 
 
The Coupled Nuclear Network in Gene Expression 
Though the gene expression pathway can be described as simple as in the Central 
Dogma of Molecular Biology: DNA→RNA→Protein, it is indeed a very complicated 
multi-step process.  Eukaryotic genes are transcribed in the nucleus into pre-mRNAs 
which undergo three major posttranscriptional processing steps (5’-capping, splicing, and 
3’-processing/polyadenylation) followed by nuclear export and translation in the 
cytoplasm.  Over the years, distinct nuclear machineries have been discovered and 
assigned to individual steps.  However, more and more recent studies have suggested 
that they are functionally coupled (reviewed in Maniatis and Reed, 2002; Fig. 5). 
 
Coupling between transcription and RNA processing 
Generally, 5’-capping, splicing, and polyadenylation are all coupled to transcription.  
Several transcription elongation factors and the carboxy-terminal domain (CTD) of the 
RNA polymerase II (RNA Pol II) large subunit have been demonstrated to function in the 
coupling.  Distinct segments of the CTD interact with different sets of protein factors  
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Figure 4.  Regulation of α- tropomyosin splicing.  Constitutive exons (1 and 4) and mutually exclusive exons (2 and 3) are 
represented by grey and colored boxes, respectively.  Introns are represented by straight lines.  Regulatory elements and alternative 
splicing factors are indicated.  ESE: exonic splicing enhancer; B2P2: branch point/polypyrimidine-tract of exon 2; B3P3: branch 
point/polypyrimidine-tract of exon 3; URE: Upstream Regulatory element; DRE: Downstream Regulatory element; H/F: hnRNP H 
and hnRNP F; ?: unkown protein factor. 
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Figure 5.  A coupled nuclear network of gene expression.  Different stages during 
transcription are indicated along the top red arrow, and steps in posttranscriptional 
processing, mRNA export, and mRNA surveillance are shown below.  Physical and/or 
functional coupling between individual steps is indicated by black arrows (adapted from 
Maniatis and Reed, 2002). 
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involved in capping, splicing, or 3’-processing (Fong and Bentley, 2001), which are 
co-transcriptionally recruited to the hyperphosphorylated CTD, and then transfer to the 
nascent pre-mRNA (Komarnitsky et al., 2000; Vagner et al., 2000).  While the CTD 
serves as a platform for assembly of pre-mRNA processing machineries, two 
transcription elongation factors, P-TEFB and TAT-SF1, have also been shown to recruit 
capping and splicing factors to the nascent pre-mRNA (Fong and Zhou, 2001; Shatkin 
and Manley, 2000). 
Since coupling of individual pre-mRNA processing events to transcription is 
potentially a more efficient mechanism to control overall gene expression, it is not 
surprising that these different processing steps are coupled as well.  Besides efficiency, 
coupling opens more opportunities for regulation.  For example, transcription from 
different promoters or the rate of elongation can alter the pre-mRNA splicing pattern 
(Cramer et al., 1999; de la Mata et al., 2003; Howe et al., 2003; Kornblihtt, 2005), 
whereas splicing factors can promote transcription elongation (Bres et al., 2005).  
Similarly, splicing of the last intron can promote downstream 3’-end cleavage and 
polyadenylation (Lou et al., 1996; McCracken et al., 2002; Vagner et al., 2000). 
 
Coupling of pre-mRNA splicing to mRNA export and NMD 
Two interesting observations have linked splicing to mRNA export and NMD, 
respectively.  First, splicing is required for efficient mRNA export (Luo and Reed, 
1999).  Second, mRNAs containing nonsense codons located more than 50-55 nt 
upstream of the last exon-exon junction are targeted for degradation (Maquat and 
Carmichael, 2001; Nagy and Maquat, 1998).  Though seemingly unrelated at first 
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glance, these two processes are actually linked by the EJC complex (Le Hir et al., 2001).  
The EJC is positioned approximately 20-24 nt upstream of exon-exon junctions upon 
completion of splicing and contains proteins involved in mRNA export (UAP56, TAP, 
REF/Aly) and NMD (Upf2, Upf3, RNPS1, Y14 and MAGOH) (reviewed in Maquat, 
2004).  Formation of the EJC targets spliced mRNA for export.  Some EJC 
components, such as Y14 and Magoh, remain associated with mRNA until removed by 
passage of ribosomes during the pioneer round of translation (Ishigaki et al., 2001; Le Hir 
et al., 2001).  This acts as a checkpoint for pre-mature stop codons (PTC).  Retained 
EJC components on an mRNA after the pioneer round of translation serve to recruit other 
NMD factors and target that mRNA to NMD (reviewed in Maquat, 2005).  Taken 
together, the EJC couples pre-mRNA splicing to mRNA export and NMD, serving as a 
crucial checkpoint for accurate splicing but, in addition, may also link splicing and 
translation since it may also promote mRNA polysome association (Nott et al., 2004). 
 
PSF: A Multifunctional Nuclear Factor 
 
PSF and its related proteins 
Human PTB-associated splicing factor (PSF; Patton et al., 1993) is a 100 kDa 
protein that co-localizes with splicing factors in nuclear speckles (Dye and Patton, 2001), 
and is comprised of an N-terminal glycine-rich domain, a proline/glutamine (P/Q) rich 
domain, two RRMs, and a C-terminal region with two nuclear localization signals (Fig. 
6).  Though first identified in a complex with PTB (Patton et al., 1993), the majority of 
PSF does not associate with PTB (Meissner et al., 2000), but is often found as a  
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Figure 6.  Structure comparison of PSF and its related proteins.  Human PSF, 
p54nrb, PSP1, mouse PSF, NonO, Drosophila NonA/BJ6, and C. tentans hrp65 are highly 
homologous over a 320 amino acid region referred to as the Drosophila Behavior, 
Human Splicing domain (DBHS; grey box; Dong et al., 1993).  This region includes the 
two RNA Recognition Motifs (RRM1 and RRM2, diagonally hatched boxes), a 
helix-turn-helix motif (HtH, horizontally hatched boxes), and a basic/acidic region (+/-, 
cross-hatched boxes).  Additional similarity exists in regions rich in glycine (G), 
asparagine (N), proline (P), and glutamine (Q) residues (black boxes). 
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heterodimer with p54nrb (Peng et al., 2002; Straub et al., 1998; Zhang et al., 1993), a 
closely related protein originally identified based on cross-reactivity to antibodies raised 
against the yeast U5 snRNP-associated second-step splicing factor Prp18 (Dong et al., 
1993).  p54nrb is 71% identical to PSF over a region of 320 amino acids that 
encompasses their RRMs (referred to as the Drosophila Behavior, Human Splicing 
domain, DBHS; Dong et al., 1993; see Fig. 6), and has been implicated in multiple 
functions involving both RNA and DNA binding (Basu et al., 1997; Peng et al., 2002; 
Sewer et al., 2002; Straub et al., 1998; Straub et al., 2000; Zhang et al., 1993; Zhang and 
Carmichael, 2001). 
Recently, another DBHS domain containing protein, Paraspeckle Protein 1 (PSP1), 
was identified in humans (Andersen et al., 2002; Fox et al., 2002).  PSP1 localizes in the 
paraspeckle, a novel nuclear domain that is usually located adjacent to splicing speckles.  
Interestingly, p54nrb, but not PSF, was also found in paraspeckles (Fox et al., 2002).  
Upon actinomycin D induced transcriptional inhibition, both PSF and the paraspeckle 
proteins (p54nrb, PSP1, PSP2) relocalize to discrete caps at the nucleolar periphery 
(Andersen et al., 2002; Dye and Patton, 2001; Fox et al., 2002; Shav-Tal et al., 2005).  
More recent proteomic studies of nucleolar dynamics revealed that after actinomycin D 
treatment, the amounts of nucleolar PSF, p54nrb, and PSP1 increased by 5, 3, and 2 fold, 
respectively, with even more accumulation of this family of proteins in the nucleolus 
after treatment with 5,6-dichlorobenzimidazole riboside, which selectively inhibits RNA 
Pol II but not Pol I (Andersen et al., 2005). 
Other homologs of PSF include mPSF (mouse PSF; Shav-Tal et al., 2001), NonO 
(mouse p54nrb; Yang et al., 1993), NonA/BJ6 (Drosophila; important in Drosophila 
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visual acuity and male courtship song; Besser et al., 1990; Jones and Rubin, 1990), and 
hrp65 (C. tentans), a component of nuclear fibers associated with specific pre-mRNPs 
(Miralles et al., 2000; Wurtz et al., 1996). 
 
PSF functions in pre-mRNA splicing. 
PSF was cloned as a protein associated with the alternative splicing factor PTB.  
Unlike PTB, PSF has been proposed to be an essential splicing factor.  
Immunodepletion of PSF from HeLa nuclear extract first suggested that PSF might play a 
role in early spliceosome formation (Patton et al., 1993) but subsequent 
depletion/repletion experiments suggested that it might be rate-limiting for the second 
step(Gozani et al., 1994).  Studies of the B complex identified both PSF and a 
degradation form of PSF (referred to as SAP102 and SAP68, respectively) as components 
of spliceosome (Bennett et al., 1992) and specific association of PSF with the C complex 
was discovered two years later (Gozani et al., 1994).  Recently, several more advanced 
analyses of spliceosomal complexes using different purification strategies detected PSF 
in both early (H, B*) and late (C) complexes (Bennett et al., 1992; Gozani et al., 1994; 
Jurica et al., 2002; Makarov et al., 2002; Rappsilber et al., 2002). 
Besides its presence in spliceosomal complexes, PSF binds U5 snRNA specifically 
(Peng et al., 2002; see Chapter II), consistent with its co-purification with U4/U6.U5 
tri-snRNP (Teigelkamp et al., 1997) and its interaction with the U5 snRNP specific 
protein hPrp8 (U5-220 kDa) (G. Moreau and M. Moore, personal communication).  
Furthermore, PSF was identified as part of a snRNP-free U1A complex, which plays a 
potential role in both splicing and polyadenylation (Lutz et al., 1998).  Konarska and  
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Figure 7.  Multiple functions have been proposed for PSF (see text for details).   
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colleagues recently showed that both PSF and p54nrb directly contact the 5’ splice site 
within large transcription/splicing complexes (Kameoka et al., 2004).  Overall, the data 
described above are consistent with a role for PSF in both early and late steps of splicing 
but exactly how it functions unknown. 
 
Potential multi nuclear functions for PSF 
Besides splicing, other nuclear functions have been proposed for PSF (Fig. 7).  In 
several cases, PSF has been implicated as a transcription regulator.  By itself, PSF 
inhibits the transcription of the porcine P-450 cholesterol side-chain cleavage enzyme 
gene (P450scc) through its interaction with the insulin-like growth factor response 
element (IGFRE) (Urban and Bodenburg, 2002; Urban et al., 2000).  Binding of the 
mouse VL30 retrotransposon RNA to PSF disassociates PSF from IGFRE, turning on 
expression of the P450scc gene (Song et al., 2004).  PSF and p54nrb have also been 
shown to bind the DNA binding domain (DBD) of nuclear hormone receptors and form a 
complex with the repressor Sin3A, inducing transcription silencing through the 
recruitment of class I histone deacetylases (HDAC) to the receptor DBD (Mathur et al., 
2001).  However, in the case of human CYP17 gene, the negative effects of PSF and 
p54nrb on transcription can be reversed by cAMP stimulation.  Increased levels of cAMP 
activate phosphatase(s), which dephosphorylate PSF/p54nrb/SF-1, releasing Sin3A/HDAC 
from the complex.  In the absence of Sin3A/HDAC, more PSF/p54nrb/SF-1 binds to 
cAMP-responsive sequences (CRS), and promotes transcription of the hCYP17 gene 
(Sewer and Waterman, 2002; Sewer et al., 2002).  The transcriptional repressing activity 
of PSF is associated with its N-terminal region (Mathur et al., 2001; Urban and 
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Bodenburg, 2002).  Recently, both PSF and p54nrb were shown to interact with the CTD 
of RNA Pol II (Emili et al., 2002).  It remains unclear whether this indicates 
involvement in coupling transcription and splicing or simply reflects participation in 
transcription regulation. 
In addition to transcriptional regulation, PSF has been proposed to regulate gene 
expression posttranscriptionally (Zhang and Carmichael, 2001; Zolutukhin et al., 2002).  
PSF has been shown to interact with cis-acting instability elements (INS) in Human 
Immunodeficiency Virus type 1 (HIV) gag/pol and env mRNAs (Zolutukhin et al., 2002).  
Binding of PSF to the INS counteracts the Rev-dependent export of these viral mRNAs 
leading to decreased virus production.  Besides HIV, PSF may play a role in retaining 
aberrant transcripts in the nucleus.  PSF, p54nrb and matrin 3 were identified in a 
complex that binds specifically and cooperatively to hyperedited inosine-containing 
RNAs.  Interestingly, these inosine-containing RNAs can be exported by Rev but are 
retained in the nucleus by the PSF/p54nrb/matrin 3 complex (Zhang and Carmichael, 
2001).  In both cases, PSF seems to counteract the nuclear mRNA export by Rev but the 
exact mechanism has not been determined.  Association of PSF with Hepatitis B Virus 
(HBV) RNA was also detected but the functional significance of such binding is not clear 
(T. Heise, personal communication). 
Roles for PSF in facilitating topoisomerase I (Top I) activity, DNA recombination, 
and DNA double-strand break rejoining have also been proposed (Akhmedov and Lopez, 
2000; Bladen et al., 2005; Straub et al., 1998; Straub et al., 2000).  Unlike the regulatory 
activities described above, most of these functions were postulated based on 
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protein-protein interactions and in vitro functional assays.  Whether such activities exist 
in vivo remains to be determined. 
 
Summary 
Pre-mRNA splicing is crucial for control of eukaryotic gene expression, and 
involves a large number of RNA and protein factors that ensure accuracy and efficiency.  
Although much progress has been achieved in our understanding of the assembly and the 
composition of the spliceosome as well as splicing regulatory elements and factors, many 
questions remain, especially in higher eukaryotes.  For example, the exact function of 
individual components of the spliceosome and any structural changes and/or factor 
requirements during the two catalytic steps.  Furthermore, the recent discovery of the 
yeast penta-snRNP raises the question as to whether pre-formed spliceosomes also exist 
in higher eukaryotes and if so, how is alternative splicing regulated.  In an even broader 
view, splicing is coupled with other nuclear events, providing many feedback loops and 
checkpoints, making a potentially more efficient and highly regulated environment for 
gene expression.  However, with the coupling network becoming more and more 
complex over time, how is overall coordination regulated? 
Most of the essential splicing factors that have been identified are involved in 
spliceosome assembly whereas a smaller number have been proposed to function in the 
second catalytic step of splicing(Chua and Reed, 1999; Gozani et al., 1994; Horowitz and 
Krainer, 1997; Lindsey et al., 1995; Lindsey and Garcia-Blanco, 1998; Zhou and Reed, 
1998).  As one of the essential factors, PSF plays an important role in both early 
spliceosome assembly and in the second step, with evidence placing it in association with 
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the 5’ splice site as well as with the U4/U6.U5 tri-snRNP. Nevertheless, exactly how it 
functions remains unknown.  Therefore, a better understanding of the role of PSF in 
splicing would lead to further insight into the mechanism of splicing.  To accomplish 
this goal, we started out with the identification of protein factors that interact with PSF 
and determined its RNA binding specificity.  This led to the discovery of a 
PSF-containing multi-snRNP complex resembling the yeast penta-snRNP.   
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CHAPTER II 
 
PSF AND P54NRB BIND A CONSERVED STEM IN U5 SNRNA. 
 
Introduction 
Most eukaryotic genes are transcribed into pre-mRNAs containing coding 
sequences (exons) disrupted by intervening sequences (introns).  Prior to translation, the 
introns must be efficiently and accurately removed and the exons joined together in a 
process known as pre-mRNA splicing (Burge et al., 1999; Hastings and Krainer, 2001).  
Splicing is carried out within the spliceosome, a large complex composed of small 
nuclear ribonucleoproteins (U1, U2, U4/U6, and U5 snRNPs; Lührmann, 1988) and other 
non-snRNP protein factors.  The joining of exons requires two transesterification 
reactions, the first of which involves cleavage of the 5’ exon and generation of a lariat 
intron-3’ exon intermediate.  The second step ligates the exons together and releases the 
intron.  SnRNPs play important roles in both spliceosome assembly and the two 
catalytic steps of splicing.  Dynamic base pairing interactions between the snRNAs and 
the pre-mRNA and between the snRNAs themselves are crucial for accurate definition of 
the exon/intron boundaries (Nilsen, 1998).  U1 base pairs with the 5’ splice site while 
U2 pairs with a region upstream of the 3’ splice site referred to as the branch point.  
Upon association with U4/U6.U5, a series of rearrangements occur, including 
dissociation of U1 from the 5’ splice site and dissociation of U4 from U6, allowing 
different regions of U6 to pair with both the 5’ splice site and with U2 snRNA.  During 
these changes, U5 appears to play an important role in tethering the two exons to 
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juxtapose them for catalysis (Alvi et al., 2001; McConnell and Steitz, 2001; Newman, 
1997; O'Keefe and Newman, 1998). 
To ensure the accuracy of splicing, these RNA rearrangements take place in a 
highly ordered and well regulated manner (Reed, 2000).  Although the mechanism of 
this is not completely understood, two groups of protein factors are thought to be 
involved.  One contains members of a superfamily of ATPases, including the DEAD 
and DEAH box families.  These ATPases are proposed to facilitate RNA 
rearrangements by unwinding RNA duplexes or by disrupting RNA-protein interactions 
(Staley and Guthrie, 1998).  The second group of factors are members of a family of 
RNA binding proteins containing RNA recognition motifs (RRMs; Burd and Dreyfuss, 
1994; Swanson, 1995).  The RRMs of these proteins are thought to mediate binding to 
single-stranded RNA, but RRMs also participate in protein-protein interactions, allowing 
this group of factors to play distinct roles in annealing critical RNA pairs, stabilizing 
single-stranded RNAs, and facilitating exon/intron definition (Fu, 1995; Ghetti et al., 
1995; Valcárcel et al., 1996).  
Most of the splicing factors that have been identified are involved in spliceosome 
assembly whereas a smaller number have been proposed to function in the second step of 
splicing (Chua and Reed, 1999; Gozani et al., 1994; Horowitz and Krainer, 1997; 
Lindsey and Garcia-Blanco, 1998; Zhou and Reed, 1998).  Human PTB-associated 
splicing factor (PSF; Patton et al., 1993) is one of these proteins.  PSF is a100 kDa 
protein that co-localizes with splicing factors in nuclear speckles (Dye and Patton, 2001), 
and is comprised of an N-terminal glycine-rich domain, a proline/glutamine (P/Q) rich 
domain, two RRMs, and a C-terminal region with two nuclear localization signals.  It 
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was first identified due to its association with Polypyrimidine-Tract Binding protein 
(PTB; Patton et al., 1991), but it appears that only a fraction of PTB co-localizes with 
PSF (Meissner et al., 2000), and the functional relevance of this interaction has not been 
demonstrated.  Immunodepletion of PSF from nuclear extract first suggested that PSF 
might play a role in early spliceosome formation (Patton et al., 1993), while subsequent 
depletion/repletion experiments suggested that PSF might be rate-limiting for the second 
step (Gozani et al., 1994).  PSF co-purifies with U4/U6.U5 tri-snRNP (Teigelkamp et al., 
1997), and, in addition, several studies using different purification strategies have 
detected PSF in both early (H, A, B) and late (C) spliceosomal complexes (Bennett et al., 
1992; Gozani et al., 1994; Jurica et al., 2002; Makarov et al., 2002; Rappsilber et al., 
2002).  Overall, the data are consistent with a role for PSF in both early and late steps of 
splicing but exactly how it functions is unknown.  That PSF could play multiple roles in 
splicing is perhaps not surprising since it has also been implicated in transcription, 
topoisomerase activity, nuclear RNA retention, DNA recombination, and DNA 
double-strand break rejoining (Akhmedov and Lopez, 2000; Bladen et al., 2005; Mathur 
et al., 2001; Sewer and Waterman, 2002; Sewer et al., 2002; Song et al., 2004; Straub et 
al., 1998; Straub et al., 2000; Urban and Bodenburg, 2002; Urban et al., 2000; Zhang and 
Carmichael, 2001; Zolutukhin et al., 2002).  Given the fact that many nuclear events are 
coupled (Maniatis and Reed, 2002), understanding the multifunctional roles of PSF could 
provide insight into overall nuclear function.   
Here, we performed yeast two-hybrid screens and identified p54nrb as a 
PSF-interacting factor.  This interaction was confirmed both by co-immunoprecipitation 
from HeLa nuclear extract, and by the association of recombinant proteins in vitro.  We 
 32
also used iterative selection techniques (SELEX; Systematic Evolution of Ligands by 
Exponential Enrichment; Szostak, 1992; Tuerk and Gold, 1990) to identify the optimal 
RNA binding sites for PSF and p54nrb.  These experiments resulted in the selection of 
RNAs matching a sequence found in the 3’ side of a conserved stem in U5 snRNA.  
Both filter binding assays and RNA affinity experiments using biotinylated U5 snRNAs 
demonstrated that the two proteins bind U5 snRNA with both the sequence and structure 
of stem 1b contributing to binding specificity.  Sedimentation analyses confirmed their 
association with spliceosomes and with U4/U6.U5 tri-snPNP.  
 
Materials and Methods 
 
Recombinant protein expression 
Full-length human p54nrb was expressed from the pGex-2T vector as an N-terminal 
fusion with GST and from the pET 28A vector (Novagen) as a his-tagged fusion.  The 
GST-p54nrb deletions described in Fig. 8 (GST-p54nrb∆17-220, GST-p54nrb∆71-220, 
GST-p54nrb∆17-369, GST-p54nrb∆71-464, and GST-p54∆226-464) were generated by 
reverse PCR using pGex-2T-p54nrb as the template (Coolidge and Patton, 1995; Imai et 
al., 1991).  Detailed cloning strategies and primer sequences are available upon request.  
All clones were verified by sequencing. 
GST-p54nrb and deletion mutants were expressed in the E. coli strain HB101, and 
pET 28A-p54nrb was expressed in BL21 (DE3)-pLysS.  Cells were grown in LB media 
at 37°C until an O.D.600 of 0.5 was attained.  Expression was induced for 3 h by the 
addition of IPTG to a final concentration of 1 mM.  GST-p54nrb fusion proteins were 
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purified by passage over glutathione agarose (Sigma), eluted with a glutathione gradient, 
and dialyzed against buffer D (20 mM Tris-HCl, pH 7.9, 100 mM KCl, 0.2 mM EDTA, 
0.5 mM DTT, 5% glycerol).  His-tagged p54nrb was purified by passage over Ni-NTA 
agarose (Qiagen) and further purified by chromatography on a Mono-S column 
(Pharmacia).  His-tagged PSF was prepared as previously described (Patton et al., 1993) 
with additional purification over a Mono-S column.  Average purity of the proteins was 
95%.  Purified proteins were dialyzed into either buffer A (Pérez et al., 1997) for use in 
SELEX assays or into buffer D for other experiments. 
 
Yeast two-hybrid screens 
Full-length PSF cDNA was cloned into the pBTM116 vector as a fusion with the 
LexA DNA binding domain and used to screen a 7-day mouse embryo cDNA library 
cloned into pVP16 and expressed as fusions with the VP16 transcriptional activation 
domain.  Bait and prey vectors were co-transformed into the yeast strain L40 (his3∆200, 
trp-901, leu2-3, 112, ade2, LYS2::(lexAop)4-HIS3, URA3::(lexAop)8-LacZ, partial 
genotype), allowing selection of positive interactions based on growth on his- plates and 
β-galactosidase activity.  Initial selection for positive clones was performed on his- 
plates containing a final concentration of 15 mM 3-amino-triazole.  β-galactosidase 
assays were performed as previously described (Kaiser et al., 1994).  
 
Immunoprecipitations 
HeLa nuclear extract (approximately 50 µg; Abmayr et al., 1988) was diluted to a 
volume of 400 µl with buffer D containing 0.5% NP-40 and incubated with 1.2 µg 
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anti-PSF antibody (Patton et al., 1993) and 15 µl (bead volume) protein G-Sepharose 
(Pharmacia) for 2 h at 4°C.  Following 3 washes with buffer D containing 0.5% NP-40, 
beads were resuspended in 20 µl 2X Laemmli loading buffer (Laemmli, 1970).  
Following separation on 9% SDS-PAGE gels, immunoprecipitated proteins were 
transferred to PVDF and p54nrb was detected by Western blot analysis using a 
monoclonal antibody raised against GST-p54nrb.  
 
PSF-p54nrb interaction assays 
In vitro translated, 35S-labeled PSF was prepared using the TNT® T7 Coupled 
Reticulocyte Lysate System (Promega).  The radiolabeled protein was diluted in PP-300 
buffer (20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 0.5 mM EDTA, 0.2% NP-40 and 0.5 
mM DTT) and mixed with equal amounts of glutathione-agarose beads to which 
GST-p54nrb or one of its deletion mutant derivatives was pre-bound.  Following 
incubation in a total volume of 225 µl at room temperature for 1 h, the beads and bound 
proteins were precipitated by brief centrifugation, and the supernatant was discarded.  
The beads were then washed 3 times with 500 µl of PP-300 and resuspended in 30 µl of 
2X Laemmli loading buffer.  Bound proteins were resolved by SDS-PAGE on 9% gels, 
and radiolabeled PSF visualized by phosphorimager analysis. 
 
Systematic Evolution of Ligands by Exponential Enrichment (SELEX) 
SELEX assays were performed using 7.5 µg of each recombinant protein in the 
binding steps, as described (Pérez et al., 1997; Tuerk and Gold, 1990).  Briefly, a pool 
of DNA (5’-GCGTCTCGAGAAGCTTCC(N20)AGTCGGGAATTCGGATCCCtatagtgagtcgtatta 
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–3’) was synthesized containing a randomized 20-nucleotide sequence (N20) flanked by 
anchor sequences that served as primer annealing sites for PCR, and for T7 RNA 
polymerase.  The amplified DNA pool was then transcribed and resulting RNAs were 
incubated with his-tagged PSF and/or his-tagged p54nrb in binding buffer (10 mM 
Tris-HCl, pH 7.5, 100 mM KCl, 2.5 mM MgCl2, 0.1% Triton X-100, 0.1 mg/ml yeast 
tRNA).  The proteins and bound RNAs were recovered with Ni-NTA agarose beads 
(Qiagen) and RNAs were recovered by phenol extraction and ethanol precipitation.  
Selected RNAs were then reverse transcribed and amplified by PCR to produce an 
enriched pool of DNA.  After 8 rounds of selection, reverse transcription, and 
amplification, the final pool was cloned and sequenced.  Prior to selection, each pool of 
RNA was incubated with Ni-NTA agarose to eliminate nonspecific binding to the beads.  
Consensus sequences were generated using the GCG DNA analysis software.  
 
In vitro transcription 
The 5’, 3’, and 5’-3’ human U5 snRNA mutants described in Fig. 11D were 
generated by site directed mutagenesis from pHU5a2 (wild type; Patton, 1991) as 
described (Coolidge and Patton, 1995; Imai et al., 1991).  All mutants were confirmed 
by sequencing, and their secondary structures analyzed by both Mfold3 (Mathews et al., 
1999; Zuker et al., 1999; http://bioinfo.math.rpi.edu/%7Emfold/rna/form1.cgi) and the 
Vienna package (Hofacker et al., 1994; http://www.tbi.univie.ac.at/cgi-bin/RNAfold.cgi).  
Wild type, 32P-CTP-labeled, U5 snRNA, unlabeled competitor RNAs and biotinylated 
RNAs were transcribed from templates (Bfa I-linearized pHU5a2) using the SP6 
MEGAscript™ in vitro transcription kit (Ambion).  Template DNAs were removed by 
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digestion with RNase-free DNase I.  Biotin was uniformly incorporated by the addition 
of biotin-14-CTP (Invitrogen), as described (Dye et al., 1998).  An adenovirus-derived 
splicing substrate RNA (AdML) was transcribed as described (Michaud and Reed, 1993).  
 
Gel shift assays 
1.3 pmol radiolabeled wild-type U5 snRNA was mixed with 5.8 pmol his-tagged 
PSF and/or 5.8 pmol his-tagged p54nrb in reactions containing 1 mM ATP, 2 mM MgCl2, 
0.5 mM DTT, 0.4 mg/ml yeast tRNA, and enough buffer D to reach 60 mM KCl in a total 
volume of 10 µl.  Reactions were incubated at 30°C for 15 min, and then stored on ice 
for additional 5 min.  Samples were separated on 5% non-denaturing polyacrylamide 
gels (50 mM Tris, 50 mM Glycine; Konarska and Sharp, 1987).  Gels were dried and 
protein-RNA complexes visualized by phosphorimager analysis. 
 
Nitrocellulose filter binding assays 
Filter binding assays were performed as described (Lynch and Maniatis, 1995).  5 
pmol radiolabeled wild-type U5 snRNA was incubated with 2 pmol his-tagged PSF 
and/or 2 pmol his-tagged p54nrb in reactions containing 1 mM ATP, 2 mM MgCl2, 0.5 
mM DTT, 0.4 mg/ml yeast tRNA, enough buffer D to reach 60 mM KCl, and the 
indicated amount of unlabeled competitor RNA in a total volume of 10 µl.  The amount 
of labeled RNA bound to filters was monitored by control reactions in which Buffer D 
was substituted for proteins.  Reactions were incubated at 30°C for 15 min, and then 
stored on ice for additional 5 min.  Samples were diluted with 90 µl wash buffer (12 
mM Tris-HCl, pH 7.9, 60 mM KCl, 0.12 mM EDTA) and immediately filtered through a 
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0.45 Micron pore nitrocellulose sandwiched in a Hybri-SlotTM manifold (Gibco-BRL).  
Filters were washed once with 200 µl wash buffer, air-dried, and the amount of retained, 
labeled U5 was quantitated. 
  
RNA affinity assays 
15 µl HeLa nuclear extract (approximately 75 µg) was incubated with 1 µg 
biotinylated RNA in each 50 µl reaction containing 0.5 mM ATP, 20 mM 
phosphocreatine, 2 mM MgCl2, 0.5 mM DTT, 15 µl buffer D and 0.3 mg/ml yeast tRNA.  
Reactions were incubated for 15 min at 30°C, chilled on ice for 5 minutes, and then 
mixed with 20 µl streptavidin-agarose beads (Sigma), pre-equilibrated in 130 µl wash 
buffer (see above) containing 1mM PMSF, 50 µg/ml yeast tRNA, 0.01% NP-40.  All 
samples were placed in 50 ml tubes packed with ice, and rocked on a tilt board at 4°C for 
30 min.  Beads were then washed twice with 200 µl ice-cold wash buffer containing 
0.005% NP-40 and resuspended in 2X Laemmli loading buffer.  Following SDS-PAGE 
on 10% gels (or 5% gels for U5-200 kDa and U5-116 kDa), proteins were transferred to 
nitrocellulose and Western blots were performed using either anti-PSF (Patton et al., 
1993), anti-p54nrb, anti-U5-116 kDa (Fabrizio et al., 1997), anti-U5-200 kDa (Lauber et 
al., 1996), anti-snRNP (from human patients), anti-SRrp86 (Barnard and Patton, 2000), 
or polyclonal anti-U2AF65 antibodies. 
 
Sucrose gradient sedimentation of snRNPs and splicing complexes 
In vitro splicing reactions using AdML pre-mRNA were carried out as previously 
described (Barnard and Patton, 2000).  For sedimentation analyses, 200 µl splicing 
 38
reactions were incubated at 30oC for 15 min, and then layered onto 10%-30% sucrose 
gradients containing 2 mM MgCl2, 0.5 mM DTT, 60% buffer D, 1 mM PMSF, 5 mM 
NaF and 0.01% NP-40.  After centrifugation in a Beckman SW-60 rotor at 25,000 rpm 
for 14 h at 4oC, fractions from the gradients were collected.  RNAs were recovered from 
each fraction by phenol/CHCl3 extraction and separated on 8M urea-15% PAGE.  
Splicing products and snRNAs were visualized by phosphorimager analysis and silver 
staining, respectively.  Proteins from each fraction were analyzed by Western blot 
analysis using different antibodies as described above. 
 
Results 
 
PSF interacts with p54nrb. 
To further define the functional role of PSF, yeast two-hybrid protein-protein 
interaction screens (Fields and Song, 1989) were performed to identify factors that 
interact with PSF.  A cDNA clone encoding PSF was fused to the LexA DNA binding 
domain and used to screen a mouse 7-day embryo cDNA two-hybrid library fused to the 
VP16 transactivation domain.  Sixty-three positive clones were sequenced and 29 were 
found to encode the mouse protein NonO (Yang et al., 1993).  NonO is the mouse 
homolog of human p54nrb (also referred to as nmt 55; Dong et al., 1993; Traish et al., 
1997), which is very similar in sequence to PSF (Fig. 8A).  For the rest of the clones, 
only the mouse RING Finger protein 4 (RNF4, accession # AF169300) and an as yet 
unidentified protein were identified five and six times, respectively, whereas none of the 
remaining clones were detected more than twice.  Interestingly, separate two-hybrid  
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Figure 8.  PSF-p54nrb interaction.  (A) Human PSF, p54nrb, mouse NonO, and 
Drosophila NonA are highly homologous over a 320 amino acid region referred to as the 
Drosophila Behavior, Human Splicing domain (DBHS; shaded box; Dong et al., 1993).  
This region includes the two RNA Recognition Motifs (RRM1 and RRM2, diagonally 
hatched boxes), a helix-turn-helix motif (HtH, horizontally hatched boxes), and a 
basic/acidic region (+/-, cross-hatched boxes).  Additional similarity exists in regions 
rich in proline (P) and glutamine (Q) residues (black boxes).  (B) Immunoprecipitation 
of HeLa nuclear extract (NE) was performed with either an anti-PSF antibody (α-PSF), 
non-immune serum (α-NI), or protein G beads alone (Resin).  Precipitated proteins were 
analyzed by Western blot analysis with an anti-p54nrb antibody.  (C) In vitro translated, 
35S-labeled PSF was incubated with the indicated GST-p54nrb constructs in the presence 
of glutathione-agarose beads.  After washing, bound proteins were eluted and resolved 
by SDS-PAGE.  Deleted regions in the GST-p54nrb mutants are represented by a thin 
line, with the numbers indicating the amino acid positions of the deleted residues.  
Domains of interest are represented as in (A). 
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screens have shown that zinc finger proteins, such as RNF4, can interact with the second 
RRM in PSF and may be involved in nuclear localization of PSF (Dye and Patton, 2001). 
The interaction between PSF and NonO/p54nrb is especially interesting since the 
two proteins are so similar.  Originally identified as a protein that cross-reacts with an 
antibody raised against the yeast U5 snRNP-associated second-step splicing factor Prp18, 
p54nrb is 71% identical to PSF over a region of 320 amino acids that encompasses their 
RRMs (Fig. 8A; Dong et al., 1993).  Other homologs of PSF and p54nrb include 
NonA/BJ6 from Drosophila, which has been shown to be important in Drosophila visual 
acuity and male courtship song (Besser et al., 1990; Jones and Rubin, 1990), hrp65 from 
C. tentans, a component of nuclear fibers associated with specific pre-mRNPs (Miralles 
et al., 2000; Wurtz et al., 1996), and PSP1 from humans, a paraspeckle protein of 
unknown function (Andersen et al., 2002; Fox et al., 2002).     
To verify that p54nrb interacts with PSF and to identify the regions of p54nrb that are 
required for binding, co-immunoprecipitation experiments and in vitro interaction assays 
were performed.  As shown in Fig. 8B, polyclonal anti-PSF antibodies were capable of 
co-immunoprecipitating p54nrb from HeLa nuclear extract, whereas p54nrb was not 
precipitated in control reactions using non-immune serum or protein G beads alone.  
The converse experiment using antibodies against p54nrb also resulted in 
co-immunoprecipitation (data not shown).  To identify which sequences of p54nrb are 
required for binding PSF, a series of glutathione-S-transferase-p54nrb fusion proteins 
(GST-p54nrb) were assayed for their ability to precipitate PSF using glutathione-agarose 
pull down assays (Fig. 8C).  Full-length GST-p54nrb and two deletion mutants 
(GST-p54nrb∆17-220 and GST-p54nrb∆71-220), both of which contain the putative 
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helix-turn-helix motif and basic/acidic region (Yang et al., 1993), were capable of 
binding PSF.  In contrast, GST fusions that lack either or both of these regions 
(GST-p54nrb∆226-464, GST-p54nrb∆71-464 and GST-p54nrb∆17-369) could not 
precipitate PSF.  Thus, it appears that the C-terminus of p54nrb is required for its 
interaction with PSF.  These results were corroborated by yeast two-hybrid assays, 
which showed that both p54nrb∆17-220 and p54nrb∆71-220 interacted with PSF in the 
two-hybrid system, whereas p54nrb∆226-464, p54nrb∆71-464, and p54nrb∆17-369, did not 
(data not shown).  When the same mapping experiments were performed with a series of 
PSF deletion constructs, only full length PSF was capable of interacting with p54nrb (data 
not shown).  It appears that multiple contacts, or a precise tertiary structure, are needed 
for PSF to interact with p54nrb.  
  
Determination of the optimal RNA binding sites of PSF and p54nrb 
Iterative selection assays (Szostak, 1992; Tuerk and Gold, 1990) were used to 
determine the optimal RNA binding sequence for PSF and p54nrb.  A pool of in vitro 
transcribed RNAs representing over 1012 different sequences was incubated with 
recombinant, hexahistidine-tagged (his-tagged) proteins, and bound RNAs were 
recovered by co-purification over Ni-NTA agarose.  Sequencing of 20 independent 
clones from the initial pool showed that the randomized region contained roughly equal 
amounts of each nucleotide (data not shown).  Prior to incubation with recombinant 
proteins, each RNA pool was pre-incubated with Ni-NTA agarose to prevent enrichment 
of nonspecific RNAs.  Following selection and amplification for eight sequential rounds, 
individual clones were sequenced.  For PSF, simple calculation of the purine and 
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pyrimidine content of the selected sequences showed enrichment for purines, from 
roughly 50% to 67% (data not shown).  When the selected sequences were compared 
using multiple alignment algorithms, a consensus sequence was identified consisting of 
5’- UGGAGAGGAAC -3’ (Fig. 9A).  Genomic data base searches with this sequence 
were not particularly useful since its length is less than the number of bases needed to 
represent a unique sequence in the human genome.  However, since PSF had been 
shown to co-purify with U4/U6.U5 tri-snRNP, we compared the consensus sequence to 
these snRNAs.  Strikingly, the selected sequence is identical to a region of U5 snRNA 
referred to as stem 1b (Fig. 9D, 9E).  
All U5 snRNAs have two stem-loop structures (Fig. 9E).  The overall secondary 
structure and particularly the 5’ loop sequence are highly conserved among all eukaryotes 
while the rest of the primary sequence is less conserved (Branlant et al., 1983; Guthrie 
and Patterson, 1988). The sequence of stem 1b, including the PSF consensus sequence, is 
remarkably conserved from flies to humans suggesting functional importance (Fig. 9D, 
9E).  Interestingly, this sequence is not found in the corresponding region of yeast U5 
snRNA, correlating with the absence of any identified PSF homologs in S. cerevisiae and 
thus far, S. pombe.   
Given the high degree of homology between the RRMs of PSF and p54nrb, the 
co-immunoprecipitation data shown in Fig. 8, and previous biochemical data suggesting 
that these proteins exist as a heterodimer (Straub et al., 1998; Zhang et al., 1993), it was 
of interest to determine the optimal RNA binding sites for p54nrb and mixtures of 
PSF-p54nrb.  As with PSF, selection with p54nrb or mixtures of PSF-p54nrb yielded 
sequences that also aligned well with the 3’ side of U5 snRNA stem 1b (Fig. 9B, 9C, 9D) 
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Figure 9.  Identification of optimal RNA binding sites for PSF and p54nrb.  Iterative selection assays were performed using a 
pool of RNAs containing 20 randomized nucleotides and either recombinant, his-tagged PSF (A), recombinant, his-tagged p54nrb (B), 
or a 1:1 mixture of PSF-p54nrb (C).  Eight rounds of transcription, selection, and amplification were performed before individual 
clones were isolated and sequenced.  Alignments of the selected sequences (numbered) and the derived consensus sequences are as 
shown.  Aligned nucleotides are displayed as capital letters on a black background, and other nucleotides that form additional 
alignments with the consensus sequence are in capital letters and underlined.  (D) Alignment of PSF and p54nrb consensus sequences 
to U5 stem 1b.  The PSF and p54nrb consensus sequences are shown aligned with the 3’ strand of U5 snRNA stem 1b sequences from 
human, rat (Rattus norvegicus), mouse (Mus musculus), chicken (Gallus gallus), frog (Xenopus laevis), fly (Drosophila melanogaster), 
and yeast (Saccharomyces cerevisiae and Schizosaccharomyces pombe) (Guthrie and Patterson, 1988).  (E) The secondary structure 
of human U5 snRNA is depicted with the PSF RNA binding consensus sequence boxed (adapted from Ségault et al., 1999). 
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This suggests that the optimal RNA binding sites for PSF and p54nrb, and/or mixtures 
thereof, are extremely similar, if not identical (Fig. 9C, 9D). 
 
PSF and p54nrb form a complex with U5 snRNA in vitro. 
It is possible that the RNA sequences selected by mixtures of PSF-p54nrb (Fig. 9C) 
were derived by interaction with individual proteins, or by interaction with PSF-p54nrb 
complexes.  We therefore examined binding of these proteins to U5 snRNA using gel 
shift assays.  In vitro transcribed, uniformly 32P-labeled, wild type U5 RNA was 
incubated with his-tagged PSF and his-tagged p54nrb (either individually or in 
combination), in the presence of excess yeast tRNA as non-specific competitor, and 
subjected to 5% native gel electrophoresis.  Upon incubation of recombinant PSF with 
wild type U5, a low mobility complex was observed (Fig. 10, lane 1).  This complex 
could be competed away by unlabeled wild type U5 snRNA, but not yeast tRNA (data 
not shown), suggesting specific interaction between PSF and U5.  When recombinant 
p54nrb was incubated with U5 by itself, no complex was detected (Fig. 10, lane 2).  In 
contrast, incubation of 1:1 mixture of recombinant PSF and p54nrb with wild type U5 
resulted in a complete shift of the PSF/U5 complex to a lower mobility complex (Fig. 10, 
lane 3), indicating that the two proteins form a complex with U5 snRNA simultaneously.   
 
Binding of PSF and p54nrb to U5 snRNA is dependent on both the sequence and 
structure of stem 1b. 
 
Proteins with RRM domains, such as PSF and p54nrb, are thought to primarily bind 
single stranded RNA.  The fact that PSF and p54nrb selected single stranded sequences 
that match the 3’ side of U5 stem 1b, and that they form a complex with U5 in vitro,
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Figure 10.  PSF and p54nrb form a complex with U5 snRNA in vitro.  In vitro 
transcribed wild type U5 RNA was incubated with his-tagged PSF (lane 1), his-tagged 
p54nrb (lane 2), or 1:1 mixture of his-tagged PSF-p54nrb (lane 3) in the presence of excess 
yeast tRNA.  The reactions were incubated at 30oC for 15 min, and complex formation 
was analyzed by 5% native gel electrophoresis.  Free RNA and protein-RNA complexes 
are indicated by arrows. 
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raised the question as to whether such interaction requires melting of stem 1b or whether 
the stem remains paired.  To analyze their interaction with U5 snRNA, filter binding 
assays were used.  In vitro synthesized, uniformly 32P-labeled, wild type U5 snRNA was 
incubated with recombinant, his-tagged PSF or p54nrb in the presence or absence of 
competitor RNAs.  Protein-RNA complexes were then separated from free RNA by 
filtration through nitrocellulose and the level of retained U5 was quantitated.  
Competitor RNAs consisted of wild type U5, U5 snRNAs containing mutations in stem 
1b, or yeast tRNA as a nonspecific control.  The different U5 snRNA mutants included 
a 5’ mutant, in which the sequence of the 5’ strand of stem 1b was changed to disrupt the 
base pairing of stem 1b without altering the optimal PSF-p54nrb binding site, a 3’ mutant 
in which the sequence of the 3’ strand of stem 1b was changed so that both the base 
pairing and the PSF-p54nrb binding site were disrupted, and a 5’-3’ double mutant in 
which compensatory changes recreated stem 1b but with altered sequence on both strands 
(Fig. 11D).  
Incubation of recombinant PSF with labeled wild type U5 led to retention of U5 
snRNA on the nitrocellulose filters whereas only small amounts of U5 were retained in 
the absence of protein (about 2% of total input).  To ensure specificity, unlabeled wild 
type U5 snRNA was included and found to effectively compete with labeled wild type 
U5, reducing the binding to 30% of maximum at a 5-fold molar excess of competitor 
RNA (Fig. 11A).  In contrast, yeast tRNA showed little competition.  Thus, it appears 
that the filter binding assay monitors specific interaction between PSF and U5.  To test 
whether stem 1b is required for interaction with PSF, competition binding experiments 
were performed with the 5’, 3’ and 5’-3’ U5 snRNA mutants.  Compared to wild type 
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Figure 11.  PSF and p54nrb bind U5 snRNA with both the sequence and structure of stem 1b contributing to binding 
specificity.  Filter binding experiments were performed with radiolabeled U5 snRNA in the presence of either his-tagged PSF (A), 
his-tagged p54nrb (B), or a mixture of his-tagged PSF-p54nrb (C).  Increasing amounts of unlabeled competitor RNAs were included 
and the decrease in binding is shown with the indicated standard deviation (n≥3). Competitor RNAs: {, wild type (wt U5); ●, the 5’ 
mutant (5’ mut); , the 3’ mutant (3’ mut); Ì, the 5’-3’ mutant (5’-3’ mut); , yeast tRNA (ytRNA).  (D)  U5 snRNA mutants 
used in filter binding experiments and RNA affinity assays.  Mutated nucleotides (circled) were changed to the bases indicated by the 
arrows.  Only the region surrounding stem 1b is shown, and no additional mutations were made outside of this region.  The 
predicted PSF-p54nrb binding site is boxed. 
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U5, the 5’ mutant could compete for binding but was not as effective a competitor as wild 
type U5.  The 3’ mutant showed some specificity for PSF binding but was consistently 
the poorest competitor at all concentrations.  Surprising results were obtained with the 
5’-3’ mutant.  We predicted that this RNA would not compete since the PSF binding site 
was completely changed, but competition assays showed that it displayed a competitive 
efficiency similar to the 5’ mutant.  Folding algorithms suggest that the compensatory 
mutations recreate stem 1b implying that the ability of this RNA to compete for PSF 
binding is due to the overall structure of the RNA rather than the sequence of the 3’ 
strand of stem 1b.  This may explain why the 5’ mutant competed less efficiently than 
wild type U5.  Combined, the three mutant RNAs suggest that optimal binding of PSF 
to U5 requires both the sequence and structure of stem 1b.  
For p54nrb, yeast tRNA was able to partially compete with labeled wild type U5 
snRNA (Fig. 11B).  Also, the 5’ mutant and the 5’-3’ mutant RNAs exhibited similar 
competitive abilities as wild type U5 snRNA, while the 3’ mutant was no more effective 
than yeast tRNA.  These results suggest that in the absence of the original stem 1b 
structure (compare the 5’ mutant with the 3’ mutant), the wild type sequence on the 3’ 
side of the stem 1b is required for specific binding of p54nrb to U5 snRNA.  However, in 
the presence of the original stem structure, the stem sequence is apparently less important 
for binding specificity (compare the 5’-3’ mutant with wild type U5).  Together, the 
binding experiments suggest that p54nrb, like PSF, binds to U5 stem 1b, and that both the 
sequence and structure of stem 1b contribute to binding specificity.   
Filter binding assays were also performed with the combination of PSF and p54nrb 
at approximately a 1:1 ratio (Fig. 11C).  Like PSF, yeast tRNA was unable to 
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out-compete binding between the PSF-p54nrb complex and wild type U5 snRNA.  The 
5’-3’ and the 5’ mutant RNAs were both effective competitor RNAs though not as 
efficient as wild type U5.  With the 3’ mutant, there was a noticeable difference in 
competitive efficiency using the PSF-p54nrb complex as opposed to the individual 
proteins.  For the combination, the 3’ mutant competed only slightly better than did 
yeast tRNA.  This suggests that the PSF-p54nrb complex, compared to each individual 
protein, binds U5 most efficiently when the sequence of the 3’ side of stem 1b is wild 
type.  However, since the 5’-3’ mutant also competes, the structure of stem 1b is also 
important for binding. 
  
PSF and p54nrb bind U5 snRNA in nuclear extract. 
The gel shift assays and filter binding assays described above were performed using 
relatively simple in vitro systems.  In contrast, assembly of nuclear U5 snRNA into U5 
snRNP and U4/U6.U5 tri-snRNP requires that multiple proteins interact with the RNA.  
To determine whether PSF and p54nrb contact U5 snRNA in the presence of snRNP 
proteins and other factors, RNA affinity selection assays were performed using 
biotinylated wild type and mutant U5 snRNAs.  Following incubation of biotinylated 
U5 snRNAs in HeLa nuclear extract under splicing conditions, associated proteins were 
captured by passage over streptavidin-agarose and subjected to Western blot analysis. 
As shown in Fig. 12, Sm proteins B/B' assembled onto the different biotinylated U5 
snRNAs with similar efficiency.  U5 snRNP-specific proteins (U5-200 kDa and U5-116 
kDa) also associated with all U5 snRNAs with only slightly variable efficiencies between 
the different U5 snRNAs.  Thus, both wild type and mutant U5 snRNAs were assembled 
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Figure 12.  RNA affinity assays.  Wild-type U5 snRNA (U5), the 5’ mutant (5’), the 
3’ mutant (3’), and the 5’-3’ double mutant (5’-3’) (shown in Fig. 11D) were transcribed 
in the presence of biotin-14-CTP.  Following incubation with HeLa nuclear extract (NE), 
biotinylated RNAs and associated proteins were captured by passage over streptavidin 
agarose.  After extensive washing, bound proteins were eluted and resolved by 
SDS-PAGE.  Mock reactions (M) were carried out in an identical manner without 
biotinylated RNA.  Western blot analysis was performed using antibodies against the 
indicated proteins. 
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into snRNPs under these conditions.  For PSF and p54nrb, both proteins associated with 
U5 snRNA in nuclear extract (Fig. 12).  PSF bound wild type U5 snRNA most 
efficiently with slightly less association with the 5’ mutant, lesser association with the 
5’-3’ mutant, and the least association with the 3’ mutant.  These results mirror the filter 
binding results shown in Fig. 11.  Likewise, the association of p54nrb with the different 
U5 snRNAs exhibited a similar pattern: wild type > the 5’ mutant > the 5’-3’ mutant > 
the 3’ mutant.  As controls, neither U2AF65 (Zamore et al., 1992) nor SRrp86 (Barnard 
and Patton, 2000) associated with any of the biotinylated U5 snRNAs.  These data 
indicate that both PSF and p54nrb can bind to U5 snRNA in the presence of multiple 
RNA-binding proteins in nuclear extract and that such interaction is dependent on the 
sequence and structure of stem 1b.  
 
PSF and p54nrb associate with U4/U6.U5 tri-snRNP and splicing complexes. 
Since the gel shift assays suggested that PSF and p54nrb might bind U5 as a complex, 
we next analyzed the distribution of PSF and p54nrb during splicing in HeLa nuclear 
extract by sucrose gradient sedimentation.  Splicing reactions using labeled pre-mRNA 
were allowed to proceed for 15 min before separation on 10%-30% sucrose gradients.  
RNAs were extracted from each fraction and separated on a 15% denaturing gel to 
identify the location of both labeled splicing RNAs as well as snRNAs.  Protein 
components of each fraction were assayed by Western blot analysis.  As shown in Fig. 
13A and 13B, pre-mRNA, mRNA, and splicing intermediates accumulated near the 
bottom of the gradient along with all five U snRNAs (fractions 17-20).  While the 
different snRNAs sedimented across the gradient, defined RNA and protein peaks could 
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Figure 13.  PSF and p54nrb associate with U4/U6.U5 tri-snRNP and splicing 
complexes.  200 µl splicing reactions using AdML pre-mRNA were separated on 
10%-30% sucrose gradients.  RNAs from each fraction (numbered) were recovered by 
phenol/CHCl3 extraction and separated on 8M urea-15% PAGE.  Splicing products and 
snRNAs were visualized by phosphorimager analysis (A) and silver staining (B), 
respectively.  Splicing RNAs and snRNAs are indicated on the right.  The position of 
U4/U6.U5 tri-snRNP is shown.  (C) Proteins from each fraction above (except fraction 
8 and 10) were analyzed by Western blot analysis using different antibodies as indicated. 
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be detected that consist of free snRNPs and U4/U6.U5 tri-snRNP (fractions 12-15; Fig. 
13B, 13C).  The majority of PSF and p54nrb sedimented near the top of the gradient 
(fractions 2-4; Fig. 13C).  However, a portion of PSF and p54nrb co-migrated with 
U4/U6.U5 tri-snRNP, and another subfraction co-sedimented with splicing complexes 
(fractions 19 and 20).  These results confirm that PSF and p54nrb associate with splicing 
complexes but that only a fraction of each protein co-sediments with such complexes. 
 
Discussion 
 
PSF and p54nrb are multifunctional interacting splicing factors. 
We have demonstrated that PSF interacts with p54nrb and that both of these proteins, 
individually and in combination, select the same optimal RNA binding sequence from 
random pools of RNA.  PSF and p54nrb share 71% identity over a 320 amino acid region 
encompassing their RRMs (Dong et al., 1993) and multiple functions have been ascribed 
to each.  PSF co-purifies with U4/U6.U5 tri-snRNP preparations (Teigelkamp et al., 
1997) and a variety of biochemical experiments indicate that PSF plays an important role 
in pre-mRNA splicing (Gozani et al., 1994; Patton et al., 1993).  In addition, roles for 
PSF in transcription, topoisomerase activity, nuclear RNA retention, DNA recombination, 
and DNA double-strand break rejoining have also been postulated (Akhmedov and Lopez, 
2000; Bladen et al., 2005; Mathur et al., 2001; Sewer and Waterman, 2002; Sewer et al., 
2002; Song et al., 2004; Straub et al., 1998; Straub et al., 2000; Urban and Bodenburg, 
2002; Urban et al., 2000; Zhang and Carmichael, 2001; Zolutukhin et al., 2002).  
Similarly, multiple functions involving both RNA and DNA binding have been proposed 
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for p54nrb (Basu et al., 1997; Sewer et al., 2002; Straub et al., 1998; Straub et al., 2000; 
Zhang et al., 1993; Zhang and Carmichael, 2001).  Several lines of evidence indicate 
that p54nrb is also involved in splicing.  First, p54nrb was originally isolated in screens 
designed to identify proteins that cross-react with antibodies against Prp18, a yeast 
second step splicing factor associated with U4/U6.U5 tri-snRNP and U5 snRNP (Dong et 
al., 1993; Horowitz and Abelson, 1993; Vijayraghavan and Abelson, 1990).  Second, 
GFP fusions and antibodies raised against p54nrb have been used to demonstrate 
localization to nuclei in a speckled pattern albeit somewhat more diffuse than some 
splicing factors (not shown).  Third, over-expression of Spi-1/PU.1, an Ets-related 
transcription factor, blocks p54nrb RNA binding which correlates with an effect on in 
vitro splicing (Hallier et al., 1996).  Lastly, in this study, PSF and p54nrb were found to 
co-sediment with splicing complexes (Fig. 13).  As to how these two proteins might 
function in splicing, early experiments showed that immunodepletion of PSF from 
splicing extracts affected both early spliceosome assembly and the second catalytic step 
(Gozani et al., 1994; Patton et al., 1993).  More recently, PSF and p54nrb have been 
found to associate with the 5’ splice site (Kameoka et al., 2004), consistent with a recent 
report that U4/U6.U5 tri-snRNP associates with the 5’ splice site (Maroney et al., 2000).  
It is possible that PSF and p54nrb interact with the 5’ splice site early in spliceosome 
assembly and that this association is maintained throughout later stages of splicing, such 
as when the 5’ splice site is positioned in proximity to U5 snRNP.  Thus, PSF and p54nrb 
appear to function in multiple steps of the splicing pathway, one of which may be 
rate-limiting for the second catalytic step.  Given recent experiments suggesting a link 
between transcription and splicing (Fong and Bentley, 2001; Fong and Zhou, 2001; 
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Maniatis and Reed, 2002; Monsalve et al., 2000), it is also possible that the multiple roles 
proposed for PSF and p54nrb indicate a potentially exciting link between these important 
nuclear functions. 
 
PSF and p54nrb bind a conserved stem in U5 snRNA. 
SELEX experiments using PSF, p54nrb, or the combination thereof, identified a 
purine-rich sequence identical to the 3’ side of U5 snRNA stem 1b as their optimal RNA 
binding sites (Fig. 9).  Previous iterative selection assays using fewer (five) rounds of 
selection with p54nrb also identified a purine rich sequence, 5’-AGGGA-3’ (Basu et al., 
1997).  Although this sequence is somewhat different from our results, closer 
examination of the selected sequences from these experiments show that they align well 
with U5 stem 1b.  For example, 29 out of 30 clones had one or more similar GGAG or 
GGAA motifs, while 10 of the clones contained the sequence 5’-UGG_GAGGAA-3’.  
Together, the SELEX experiments suggest that both PSF and p54nrb bind stem 1b.   
Binding of PSF and p54nrb to U5 was first verified by gel shift assays, then analyzed 
by filter binding assays and affinity selection experiments (Figs. 3-5).  In gel shift assays, 
PSF/U5 complex was completely super-shifted by the addition of p54nrb, resulting in a 
PSF-p54nrb/U5 complex (Fig. 10).  Although we cannot exclude the possibility that the 
two proteins have individual binding sites on U5 snRNA, the fact that they selected the 
same sequence (the 3’ side of U5 snRNA stem 1b) suggests they bind to U5 stem 1b as a 
complex, consistent with previous reports (Straub et al., 1998; Zhang et al., 1993).  In 
agreement with this, nuclear PSF and p54nrb showed similar distribution patterns after 
sucrose gradient sedimentation (Fig. 13).  In contrast, no p54nrb/U5 complexes were 
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observed in gel shift assays but such interactions were clearly detectable in filter binding 
experiments.  Thus, p54nrb by itself may bind U5 snRNA weakly, but such interaction 
might be stabilized by the presence of PSF.   
Binding specificity for both proteins appears to depend on multiple elements, 
including the predicted binding sequence on the 3’ side of stem 1b.  The importance of 
the 3’ strand of the stem 1b was first identified in SELEX assays and confirmed using the 
5’ and 3’ mutant U5 snRNAs.  In both the filter binding assays and the 
biotinylated-RNA selection experiments, PSF and p54nrb bound to wild type U5 and the 
5’ mutant RNA more efficiently than to the 3’ mutant.  However, the importance of the 
stem structure was shown using the 5’-3’ double mutant.  Since the 5’-3’ mutant lacks 
the optimal binding sequence for PSF-p54nrb, it seems that the structure of stem 1b 
contributes to binding specificity as well.  While we have not experimentally verified 
whether the 5’-3’ mutant adopts a structure identical to wild type U5, computer folding 
algorithms predict the same secondary structure.  Whether other factors also contribute 
to binding specificity remains unclear.  Secondary structure predictions of the 5’ and 3’ 
mutants suggest that these mutations primarily affect the structure of stem 1b with minor 
disruption of immediately adjacent structures (IL1 and IL2).  The weak but detectable 
binding of PSF and p54nrb to the 3’ mutant implies that regions other than stem 1b might 
also be involved in binding.  
 
Association of PSF and p54nrb with U5 snRNA during splicing 
Double-stranded RNAs adopt the A-form conformation which precludes 
base-specific interaction with protein side chains in the deep major groove (Steitz, 1999).  
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Therefore, the question arises as to how PSF and p54nrb interact with an A-form helix 
while apparently maintaining sequence specificity.  One speculative possibility is that 
PSF and p54nrb could bind U5 in two ways: to the intact stem, or to the 3’ side of the stem 
after melting.  At least two ATPases (U5-100 kDa and U5-200 kDa) and one homolog 
of EF-2 GTPase (U5-116 kDa) have been found to associate with U5 snRNP and may 
function to mediate unwinding to facilitate the multiple RNA-RNA rearrangements that 
are central to splicing (Fabrizio et al., 1997; Laggerbauer et al., 1998; Teigelkamp et al., 
1997).  Interestingly, hPrp8 (U5-220 kDa), which makes multiple contacts with the 
pre-mRNA and with U5 (Chiara et al., 1997; MacMillan et al., 1994; Reyes et al., 1996), 
forms a stable complex with three U5 proteins (U5-200, U5-116, and U5-40; Achsel et al., 
1998).  IL2, the internal loop between stem 1b and 1c, is required for efficient 
association of hPrp8 and U5-116 kDa with U5 (Hinz et al., 1996; Ségault et al., 1999).  
Given that the U5-200 kDa protein is a putative unwindase, it seems reasonable to 
propose that stem 1b of U5 might also undergo a conformational change during 
spliceosome assembly or during the two catalytic steps.  Interestingly, two-hybrid 
screens using fragments of hPrp8 have detected interaction with PSF (G. Moreau and M. 
Moore, personal communication), consistent with association of these two proteins to U5 
in the vicinity of stem 1b.  
As to how PSF and p54nrb might function in this process, there are at least two 
possibilities.  First, PSF and p54nrb may initially bind to double stranded stem 1b but 
then bind more tightly to the 3’ side of the stem upon unwinding.  Such binding could 
stabilize the unpaired strands coincident with U4/U6.U5 tri-snRNP contacting the 5’ 
splice site, or perhaps during the second step of splicing.  Second, given that PSF has 
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been demonstrated to promote the annealing of DNA (Akhmedov and Lopez, 2000), PSF 
and p54nrb could facilitate the reannealing of U5 stem 1b subsequent to melting, mediated 
by one or more unwindases.  Either way, the interaction could be transient, supported by 
non-stoichiometric association of PSF with U4/U6.U5 tri-snRNP (Teigelkamp et al., 
1997), and the fact that only a small amount of PSF and p54nrb co-sedimented with 
U4/U6.U5 tri-snRNP and with splicing complexes (Fig. 13).   
The high degree of conservation of U5 stem 1b in vertebrates and flies implies that 
it plays a critical role in U5 function.  Ségault et al. (1999) examined the ability of 
several human U5 snRNA mutants to function in splicing by reconstituting U5-depleted 
nuclear extract with in vitro transcribed mutant U5 snRNAs.  Although the rescue of 
splicing was prevented by deletion of IL2, a stem 1b mutant (sub-stem 1b) was still 
partially functional, perhaps suggesting that this region is not important after all.  
However, the sub-stem 1b mutant maintained a purine-rich sequence of 
5’-CAGAGAGAAGU-3’ on the 5’ side of the stem.  Comparison of this sequence with 
the 3’ strand of the original stem (the optimal PSF-p54nrb binding site) showed that all the 
changes are transitions, while most of our changes are transversions.  Furthermore, 
about 50% of the SELEX sequences we identified contain at least one AGAG or GAAG 
motifs (Figs. 9A, 9B, 9C).  Thus, it is possible that the sub-stem 1b mutant fortuitously 
maintained a binding site for PSF and p54nrb on the 5’ side of stem 1b.  
Unlike higher eukaryotes, the PSF-p54nrb binding site is not present in the 
corresponding regions of yeast U5 snRNA (Fig. 9D). This lack of conservation, together 
with the apparent absence of PSF and p54nrb homologs in yeast, suggests either that yeast 
U5 functions differently from that of higher eukaryotes, or that yeast contain an as yet 
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unidentified functional homolog of PSF and p54nrb.  Regardless, the data presented in 
this paper show that PSF and p54nrb interact with stem 1b of U5 snRNA, requiring both 
the sequence and structure for binding.  Detailed analysis of the effects that PSF and 
p54nrb have on U5 snRNA will be required to determine the exact role these proteins play 
in early/late steps of splicing, and any potential links between transcription and splicing. 
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CHAPTER III 
 
THE SPLICING FACTOR PSF IS PART OF A MAMMALIAN MULTI-SNRNP 
COMPLEX. 
 
Introduction 
 
Most eukaryotic genes are transcribed into pre-mRNA containing coding sequences 
(exons) disrupted by intervening sequences (introns).  Prior to translation, the introns 
must be efficiently and accurately removed and the exons joined together in a process 
known as pre-mRNA splicing (Burge et al., 1999; Hastings and Krainer, 2001).  
Splicing occurs in two sequential transesterification reactions, the first of which involves 
cleavage of the 5’ exon and generation of a lariat intron-3’ exon intermediate.  The 
second step ligates the exons together and releases the lariat intron.  Splicing is carried 
out within the spliceosome, a large complex composed of small nuclear ribonucleoprotein 
particles (U1, U2, U4/U6, and U5 snRNPs; Lührmann, 1988) and other non-snRNP 
protein factors (reviewed in Jurica and Moore, 2003).  snRNPs play important roles in 
both spliceosome assembly and the two catalytic steps.  The various interactions 
between the pre-mRNA, snRNPs, and other splicing factors are crucial for precise 
definition of the exon/intron boundaries (reviewed in Staley and Guthrie, 1998).  
Based on studies using cell extracts and in vitro splicing, most of the current models 
of spliceosome formation suggest a stepwise assembly pathway that requires ATP and 
substrate pre-mRNAs.  The process begins with recognition of the 5’ splice site by U1 
snRNP and the polypyrimidine-tract by the U2 snRNP auxiliary factor (U2AF) 
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heterodimer, initiating the formation of a discrete early complex (E complex).  Binding 
of U2AF to the polypyrimidine-tract recruits U2 snRNP to the branch point sequence, 
forming complex A which is converted to the B complex upon the addition of the 
U4/U6.U5 tri-snRNP.  A series of dynamic RNA/protein rearrangements then converts 
the B complex to the C complex, the short-lived, active spliceosome (reviewed in Reed 
and Palandjian, 1997).  Over the years, individual spliceosomal complexes have been 
purified and their contents analyzed by different strategies (reviewed in Jurica and Moore, 
2003).  The common theme linking these studies has been the demonstration that the 
spliceosome is a dynamic entity.  However, to what extent this model reflects the in vivo 
situation is not entirely clear.  In 2002, two different endogenous complexes were 
isolated from yeast.  The first complex, the penta-snRNP from S. cerevisiae, contains all 
five U snRNPs, and, while not functionally active by itself, appears to be a bona fide 
splicing complex since the addition of soluble factors to the complex restores activity 
(Stevens et al., 2002).  The second one, the Cwf/Cwc complex, was purified from both S. 
cerevisiae and S. pombe and appears to be similar to mammalian C complexes (Jurica et 
al., 2002; Ohi et al., 2002).  However, the Cwf/Cwc complex can be purified from 
splicing deficient strains raising questions as to its functional relevance (Ohi et al., 2002).  
Nevertheless, the identification of this complex again raises the question as to whether 
pre-formed spliceosomes might exist.  In mammalian cells, large ribonucleoprotein 
particles containing all five U snRNPs have been purified by Sperling and colleagues 
(Muller et al., 1998), but these particles are highly likely to represent endogenous 
pre-mRNP/spliceosomes.  Therefore, no particle representing pre-formed splieosome 
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complexes has been purified from mammalian extracts so far, it remains unclear whether 
the pre-assembly is limited to yeast only. 
Human PTB-associated splicing factor (PSF; Patton et al., 1993) is a 100 kDa 
protein that co-localizes with splicing factors in nuclear speckles(Dye and Patton, 2001), 
and is comprised of an N-terminal glycine-rich domain, a proline/glutamine (P/Q) rich 
domain, two RNA recognition motifs (RRMs), and a C-terminal region with two nuclear 
localization signals.  PSF has been proposed to be essential for both the early and late 
steps of pre-mRNA splicing (Gozani et al., 1994; Patton et al., 1993).  PSF co-purifies 
with the U4/U6.U5 tri-snRNP (Teigelkamp et al., 1997), possibly through its interaction 
with U5 snRNA stem 1b (Peng et al., 2002; also see Chapter II).  Different purification 
strategies have detected PSF in both early (H, A, B) and late (C) spliceosomal complexes 
(Bennett et al., 1992; Gozani et al., 1994; Jurica et al., 2002; Makarov et al., 2002; 
Rappsilber et al., 2002).  Besides its role in splicing, PSF has also been implicated in 
transcription, topoisomerase activity, nuclear RNA retention, DNA recombination, and 
DNA double-strand break rejoining (Akhmedov and Lopez, 2000; Bladen et al., 2005; 
Mathur et al., 2001; Sewer and Waterman, 2002; Sewer et al., 2002; Song et al., 2004; 
Straub et al., 1998; Straub et al., 2000; Urban and Bodenburg, 2002; Urban et al., 2000; 
Zhang and Carmichael, 2001; Zolutukhin et al., 2002).  Recently, both PSF and its 
highly related protein p54nrb were shown to interact with the C-terminal domain (CTD) of 
RNA Pol II (Emili et al., 2002) and contact the 5’ splice site within large 
transcription/splicing complexes (Kameoka et al., 2004), suggesting potential 
involvement in the coupling between transcription and splicing. 
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Previously, we showed that PSF and p54nrb interact with U5 snRNA (Peng et al., 
2002; also see Chapter II).  During further analysis of this interaction using 
immunoprecipitation (IP) by PSF-specific antibodies, all five U snRNPs were found to 
co-IP with PSF when HeLa nuclear extracts were adjusted to splicing conditions, 
regardless the addition of pre-mRNA.  Sedimentation analyses confirmed the formation 
of large PSF-containing multi-snRNP complexes (PCC complexes) in adjusted nuclear 
extracts.  The PCC complex contains all of the five splicing snRNPs, and has a size 
close to the spliceosome.  Interestingly, neither exogenous pre-mRNA nor ATP 
hydrolysis is required for the formation of the PCC complex.  Mass spectrometry 
analysis revealed remarkably similar protein components, including many 
splicing-related protein factors, between complexes that formed in the absence or 
presence of pre-mRNA.  This suggests that pre-formed spliceosomes and/or 
penta-snRNPs may also exist in mammalian cells. 
 
Materials and Methods 
 
In vitro transcription and splicing 
In vitro transcription and splicing reactions were carried out as previously described  
(Barnard and Patton, 2000; Michaud and Reed, 1993).  The adenovirus-derived splicing 
substrate RNA (AdML) was linearized with BamHI and transcribed with T7 RNA 
polymerase (Promega), whereas the antisense RNA was linearized with EcoRI and 
transcribed with SP6 RNA polymerase (Promega).  In vitro splicing reactions were 
carried out in HeLa nuclear extracts (Abmayr et al., 1988) at 30℃.  Products were 
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resolved on 8M urea-15% PAGE.  Splicing complexes formed at different time points 
were analyzed by 4% native gel electrophoresis as previousely described (Patton et al., 
1993). 
 
Formation of the PCC 
HeLa nuclear extracts were adjusted to splicing conditions (12 mM Tris-HCl, pH 
7.9, 60 mM KCl, 0.12 mM EDTA, 0.5 mM ATP, 20 mM phosphocreatine, 2 mM MgCl2, 
and 0.5 mM DTT) with or without addition of in vitro transcribed RNAs, and incubated 
on ice or at 30℃ for 0-15 mins as indicated in Results. 
 
Depletion of endogenous poly(A) RNA from HeLa nuclear extarcts 
300 µl HeLa nuclear extracts were adjusted to buffer 500 (20 mM Tris-HCl, pH 7.9, 
500 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, and 1 mM PMSF), and incubated with 10 
mg oligo-dT conjugated cellulose at room temperature for 30 min.  Reactions were then 
centrifuged and supernatant dialyzed against buffer D (20 mM Tris-HCl, pH 7.9, 100 mM 
KCl, 0.2 mM EDTA, 0.5 mM DTT, 5% glycerol) for 2h at 4℃. 
 
Immunoprecipitation 
Anti-PSF-coupled protein A sepharose was prepared as previously described 
(Harlow and Lane, 1988).  30 µl HeLa nuclear extracts (approximately 150 µg) were 
adjusted to splicing conditions (see above) to allow formation of the PCC.  For control, 
30 µl HeLa nuclear extracts without adjustment were diluted with 20 µl buffer D to 
maintain the same protein concentration.  After incubation at indicated temperature and 
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time points, reactions were diluted with 50 µl IP buffer (60% buffer D containing 1 mM 
PMSF and 0.01% NP40), rotated at 4℃ for 30 min, and centrifuged at full speed for 30 
sec to remove any aggregates.  Reactions were further diluted to 200 µl with IP buffer, 
and then incubated with 25 µl anti-PSF-coupled protein A sepharose (or 25 µl protein A 
sepharose as control) at 4℃ for 1h, followed by 3 washes with either low salt wash buffer 
(20 mM Tris-HCl, pH 7.9, 100 mM KCl, 0.2 mM EDTA, and 0.005% NP-40) or high salt 
wash buffer (20 mM Tris-HCl, pH 7.9, 250 mM KCl, 0.2 mM EDTA, and 0.005% 
NP-40).  Immunoprecipitated RNAs were recovered from beads by phenol/CHCl3 
extraction and separated on 8M urea-15% PAGE.  Splicing products and snRNAs were 
visualized by phosphorimager analysis and silver staining, respectively.  For large-scale 
purification of the PCC for mass spectrometry analysis, 90 µl HeLa nuclear extracts and 
75 µl anti-PSF-coupled protein A sepharose (or protein A sepharose as control) were 
used for each reaction, immunoprecipitated proteins were eluted by 8M urea-50 mM 
Tris-HCl, pH 8.0. 
 
Mass spectrometry analysis 
Multidimensional liquid chromatography coupled with tandem mass spectrometry 
(Link et al., 1999) was used to identify protein composition of the PCC as described 
previously (Li et al., 2003).  Acquired tandem mass spectral data were searched against 
a human subset of the National Center for Biotechnology Information nonredundant 
protein database.  Data processing of the SEQUEST output files was performed as 
previously described (Link et al., 1999). 
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Gradient sedimentation of the PCC and spliceosomes 
HeLa nuclear extracts adjusted to splicing conditions with or without addition of 
radiolabeled AdML pre-mRNA were incubated at 30℃ for 15 min to allow formation of 
the PCC.  For sedimentation analyses, 200 µl of each reaction was layered onto 
10%-30% sucrose gradients (or 5%-20% glycerol gradients) containing 2 mM MgCl2, 0.5 
mM DTT, 60% buffer D, 1 mM PMSF, 5 mM NaF and 0.01% NP-40.  After 
centrifugation in a Beckman SW-60 rotor at 54,000 g for 3, 4, or 12.5 h (as indicated in 
Results) at 4℃, fractions from the gradients were collected.  RNAs were recovered from 
each fraction by phenol/CHCl3 extraction and separated on 8M urea-15% PAGE.  
Splicing products and snRNAs were visualized by phosphorimager analysis and silver 
staining, respectively.  Proteins from each fraction were separated on 10% SDS-PAGE, 
and transferred to nitrocellulose.  Western blots were performed using either anti-PSF 
(Patton et al., 1993) or anti-U5-116 kDa (Fabrizio et al., 1997) antibodies. 
 
Results 
 
All five U snRNPs co-immunoprecipitate with PSF in HeLa nuclear extracts 
adjusted to splicing conditions without addition of pre-mRNA. 
 
In Chapter II, we showed that PSF and its closely related protein p54nrb bind the 
conserved stem 1b in U5 snRNA and that both proteins, together with other U5-specific 
factors, assemble onto biotinylated U5 snRNAs in Hela nuclear extracts under splicing 
conditions (12 mM Tris-HCl, pH 7.9, 60 mM KCl, 0.12 mM EDTA, 0.5 mM ATP, 20 
mM phosphocreatine, 2 mM MgCl2, and 0.5 mM DTT; Peng et al., 2002).  When we 
utilized PSF-specific antibodies to further analyze its interaction with U5, we found that 
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all five snRNPs could be immunoprecipitated (Fig. 14A, lane 4).  U1, U4, U5, and U6 
were present in the IP pellet in approximately stoichiometric amounts while slightly more 
U2 was detected.  In this experiment (shown in Fig. 14A, lane 4), immunoprecipitation 
was performed on reactions containing AdML pre-mRNA under splicing conditions.  
The ability to co-IP splicing substrates and intermediates with PSF (Fig. 14B) is 
consistent with co-sedimentation of PSF with splicing complexes (Chapter II Fig. 13).  
However, to our surprise, similar if not identical results were also obtained when 
immunoprecipitation reactions were performed under splicing conditions but without the 
addition of AdML pre-mRNA (Fig. 14A, compare lanes 3 and 4).  In contrast, only 
background levels of U1 and U2 snRNPs were pulled down by PSF antibodies in nuclear 
extracts that were not adjusted to splicing conditions (compare lanes 1 and 2).  It 
appears that when nuclear extracts are adjusted to splicing conditions, PSF associates 
with all snRNPs, regardless of the presence of exogenous pre-mRNA. 
 
Formation of PSF-containing multi-snRNP complexes in HeLa nuclear extracts 
under splicing conditions without addition of pre-mRNA.  
 
To determine whether PSF interacts with individual snRNPs or is part of a larger 
complex containing all 5 snRNPs, sedimentation analyses were performed.  HeLa 
nuclear extracts or extracts adjusted to splicing conditions without addition of pre-mRNA 
were incubated at 30℃ for 15 minutes and then separated on 10%-30% sucrose gradients 
(54000g, 3h).  In Hela extracts, both PSF and the U5 snRNP specific protein 
U5-116kDa sedimented near the top of the gradient (Fig. 15A, fractions 5 and above) 
with no association of PSF in complexes larger than the U4/U6.U5 tri-snPNP (fractions 
4-5).  However, when nuclear extracts were adjusted to splicing conditions minus
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Figure 14.  All of the five splicing snRNPs co-immunoprecipitate with PSF in HeLa 
nuclear extracts adjusted to splicing conditions without addition of pre-mRNA.  
HeLa nuclear extracts (NE) and nuclear extract adjusted to splicing conditions with (+) or 
without (-) addition of AdML pre-mRNA were incubated at 30℃ for 15 mins, and then 
subjected to immunoprecipitation by anti-PSF-coupled protein A sepharose.  RNAs 
were recovered from IP pellets by phenol/CHCl3 extraction and separated on 8M 
urea-15% PAGE.  U snRNAs and splicing products were visualized by silver staining 
(A) and PhosphorImage analysis (B), respectively.  
1      2      3      4
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Figure 15.  Formation of PSF-containing multi-snRNP complexes in adjusted HeLa 
nuclear extracts without addition of pre-mRNA.  (A) HeLa nuclear extracts (with or 
without adjustment, as indicated) were incubated at 30℃ for 15 mins, and then separated 
on 10%-30% sucrose gradients at 20k rpm for 3h.  Proteins from each fraction were 
analyzed by Western Blot analysis using different antibodies as indicated.  Positions of 
U4/U6.U5 tri-snRNP and spliceosomes were indicated.  (B) Splicing reactions using 
AdML pre-mRNA were incubated at 30℃ for 15 mins, and then separated on a parallel 
sucrose gradient.  RNAs were recovered from each fraction by phenol/CHCl3 extraction 
and separated on 8M urea-15% PAGE.  Splicing products were visualized by 
PhosphorImage analysis.  (C) RNAs from (A) (splicing conditions no pre-mRNA, 
fractions 7-8) were recovered as in (B), and visualized by silver staining.  (D) Adjusted 
nuclear extracts as in (A) were incubated at 30℃ for 15 mins, followed by separation on 
a 5%-20% glycerol gradient at 20k rpm for 4h.  Proteins from each fraction were 
analyzed by Western Blot analysis using PSF antibodies. 
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pre-mRNA substrate, the distribution of PSF and U5-116kDa changed.  In addition to 
free protein at the top of the gradient, a fraction of both PSF and U5-116kDa sedimented 
across the gradient.  The heaviest fraction pelleted to the bottom of the gradient and did 
so even when centrifugation speeds and times were significantly shortened, suggesting 
the formation of nonspecific aggregates (data not shown).  However, fractions 6-11 
contained PSF in complexes similar in size to mammalian spliceosomes (indicated by the 
peak of ADML pre-mRNA, mRNA, and splicing intermediates in parallel gradients, Fig. 
15B, fractions 6-9).  These fractions contain stoichiometric amounts of all 5 snRNPs 
(Fig. 15C), consistent with the IP results above.  That these fractions represent a distinct 
complex was determined by further analysis using different sedimentation conditions 
which showed three distinct peaks (Fig. 15D): free protein and that associated with the 
tri-snRNP, a lighter fraction (fractions 13-14) we are naming PCC (PSF-Containing 
Complex), and a nonspecific aggregate.  The PCC complex sediments at approximately 
60S, similar in size to mammalian spliceosomes (Fig. 16). 
 
Formation of the PCC complex is ATP-independent. 
We next used immunoprecipitation experiments to further analyze the formation of 
the PCC complex in the presence or absence of pre-mRNA and at different time points.  
As determined by the presence of all 5 snRNPs, we could detect the formation of the 
PCC regardless of the presence or absence of pre-mRNA substrate or a negative control 
antisense RNA transcript.  Interestingly, we could IP all 5 snRNPs even when reactions 
were assembled and kept on ice (time 0) and the amount and composition of the U 
snRNPs remained unchanged during continued incubation at 30℃ for 5-15 minutes (Fig. 
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Figure 16.  The PCC has a size around 60S.  HeLa nuclear extracts were adjusted to 
splicing conditions with or without AdML pre-mRNA and incubated at 30℃ for 15 mins, 
followed by separation on 10%-30% sucrose gradients at 20k rpm for 12.5h.  Size 
standards (catalase, 11S; thyroglobulin, 19S; small subunit of E.coli ribosome, 30S; large 
subunit of E.coli ribosome, 50S; 70S E.coli ribosome) were separated on parallel 
gradients. 
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17A).  As there is no ATP hydrolysis in reactions kept on ice, the formation of the 
complex is ATP-independent.  
For reactions assembled in the presence of pre-mRNA substrate, splicing did not 
affect the ability to IP all 5 snRNPs (Fig. 17B, C).  For comparison, parallel splicing 
reactions were incubated at 30℃ and splicing complexes were analyzed on 4% native 
gels.  As expected, H, A, and B/C complexes were readily detected at different time 
points, however, the pattern of snRNP IP with PSF antibodies across the same time points 
was the same.  This raises the possibility that the PCC could be unrelated to splicing, 
that the PCC complex represents endogenous pre-mRNPs, or that the PCC exists as a 
pre-formed particle which then assembles onto AdML pre-mRNAs and functions in 
splicing. 
 
The PCC complex forms in HeLa nuclear extracts depleted of endogenous polyA 
RNAs. 
 
To address whether a pool of endogenous pre-mRNA is responsible for the 
complexes we observe, we treated HeLa nuclear extracts with oligo-dT conjugated beads 
to deplete any endogenous poly(A) RNAs.  Formation of the PCC complex in depleted 
nuclear extracts was then analyzed by IP using PSF antibodies under splicing conditions.  
As shown in Fig. 18, all 5 snRNPs could be immunoprecipitated in poly(A)-depleted 
extracts, regardless of the presence or absence of subsequently added pre-mRNA 
substrate (Fig. 18A, lanes 4 and 5).  To ensure that such depletion did not abolish 
splicing activity, we performed in vitro splicing in normal and depleted extracts (Fig. 
18B).  The efficiency of splicing was a bit less in treated extracts but this was consistent 
with the fact that the efficiency of snRNP immunoprecipitation was also slightly less in
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Figure 17.  Formation of the PCC is ATP-independent.  HeLa nuclear extracts 
adjusted to splicing conditions with (+) or without (-) addition of AdML pre-mRNA, or 
with anti-sense AdML (anti-sense), and nuclear extract (NE) were incubated at 30℃ for 0, 
5, 10, 15 mins as indicated, and then subjected to immunoprecipitation by 
anti-PSF-coupled protein A sepharose.  RNAs were recovered from IP pellets by 
phenol/CHCl3 extraction and separated on 8M urea-15% PAGE.  (A) U snRNAs were 
visualized by silver staining.  (B) Splicing products from (+) pre-mRNA reactions 
(splicing reactions) were visualized by PhosphorImage analysis.  (C) Parallel splicing 
reactions were incubated at 30℃, and splicing complexes formed at different time points 
(0, 5, 10, 15 mins as indicated) were analyzed by 4% native gel electrophoresis. 
 
 77
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18.  Depletion of endogenous poly(A) RNA did not affect the formation of 
the PCC.  (A) Poly(A) RNA-depleted HeLa nuclear extracts (by treatment with 
oligo-dT conjugated cellulose) and normal extracts were adjusted to splicing conditions 
with or without addition of AdML pre-mRNA.  Reactions were incubated at 30℃ for 15 
mins before immunoprecipitation by anti-PSF-coupled protein A sepharose.  RNAs 
were recovered from IP pellets by phenol/CHCl3 extraction, separated on 8M urea-15% 
PAGE, and visualized by silver staining.  (B) Splicing reactions using radiolabeled 
AdML pre-mRNA were carried out in either poly(A)-depleted or normal nuclear extracts 
for 15 and 30 min.  RNAs were recovered as in (A), and visualized by PhosphorImage 
analysis. 
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the treated extracts.  Nevertheless, the depletion of poly(A) RNA from nuclear extracts 
did not significantly affect the formation of the PCC complex with the caveat that low 
levels of endogenous pre-mRNA may still persist in the treated extracts. 
 
The protein contents of PCC complexes formed in the absence or presence of 
pre-mRNA are remarkably similar. 
 
The presence of five U snRNPs in the PCC complex suggests the possibility that it 
might be a “mammalian penta-snRNP”.  Just like the yeast penta-snRNP, the PCC 
complex is less stable than other splicing-related complexes that have been purified.  
The PCC can withstand up to 100 mM KCl washes and completely dissociates in 250 
mM KCl (data not shown).  Despite this, we decided to utilize multidimensional liquid 
chromatography coupled with tandem mass spectrometry (Link et al., 1999) to compare 
the composition of proteins immunoprecipitated with anti-PSF antibodies under splicing 
conditions and in the absence or presence of pre-mRNA substrate.  Samples from mock 
IP (no PSF antibodies) and from IP of standard HeLa nuclear extracts were also included 
as controls.  Not surprisingly, given the relatively nonstringent conditions, many 
proteins were detected in the IP pellets.  To facilitate analysis, proteins detected in the 
mock IP were subtracted as nonspecific contaminants.  Also, since the PCC complex 
does not form in standard nuclear extracts and dissociates in 250 mM KCl, proteins 
identified in IP pellets from nuclear extracts and from high salt wash conditions were also 
subtracted as non-complex-related proteins even though this resulted in the subtraction of 
more than ten hnRNPs, several known PSF interacting factors (such as matrin 3), heat 
shock proteins, 40S ribosomal proteins, and a variety of other proteins whose role in 
splicing or RNA processing is unknown. 
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From mass spectrometry, the immunoprecipitated proteins are summarized in Table 
2, grouped into seven classes: snRNP proteins (U snRNP-specific proteins and Sm 
proteins), splicing factors, hnRNPs, RNA unwindases, transcription factors, Ser/Thr 
kinases, and factors involved in other RNA processing events (mRNA stability, mRNA 
export, mRNA 3’-processing, etc).  Among the proteins, 70% are related to pre-mRNA 
splicing and the majority of these have also been identified in other purified splicing 
complexes, such as human prespliceosomes isolated by Luhrmann and colleagues 
(Hartmuth et al., 2002).  A remarkable concordance was observed between the pattern 
of proteins in complexes formed in the presence or absence of pre-mRNA substrate.  
Several snRNP proteins, non-snRNP splicing factors, SR proteins, hnRNP proteins, and 
other RNA binding proteins involved in mRNA export and 3’-processing were detected 
in both complexes.  Among four RNA unwindases identified, DDX9 (RNA Helicase A) 
and UAP56, which function in both spliceosome assembly and mRNA export (Fleckner 
et al., 1997; Luo et al., 2001) associated with only the (+) pre-mRNA preparation.  
Three Ser/Thr kinases were found only in the PCC complex formed in the absence of 
pre-mRNA, two of them, CK II and CaMK II, have been implicated in spliceosome 
assembly and pre-mRNA splicing (Parker and Steitz, 1997; Trembley et al., 2005). 
From the above, we have shown that the PCC complex contains all of the five 
splicing snRNPs and other non-snRNP splicing factors.  Considering that nearly 70% of 
the PCC proteins are known spliceosome components, or proteins related to splicing, it is 
reasonable to speculate that the PCC complex might be functionally related to splicing.  
The fact that neither the presence of exogenous pre-mRNA substrate nor ATP hydrolysis 
is required for its formation suggests that the PCC most closely resembles the yeast  
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Table 2.  Proteins identified in PCC complexes.  Proteins identified in PCC 
complexes that formed in the absence (-) and presence (+) of AdML pre-mRNA as listed.  
●: proteins found only in the PCC; ○: proteins also present in IP pellet from nuclear 
extracts or high salt wash (see text for details). 
 
Category/function Protein name (-) pre-mRNA (+) pre-mRNA 
snRNP proteins     
sm proteins B/B' ○ ○ 
 D1 ○ ○ 
 D2 ○ ○ 
 D3 ○  
 E  ● 
 F ○ ○ 
 G ●  
U1 snRNP U1 70K ● ● 
 U1 C  ○ 
U2 snRNP U2 A' ● ● 
 U2 B'' ●  
 SF3a120 ● ● 
 SF3a66  ● 
 Sf3a60  ● 
 SF3b150 ● ● 
 SF3b130 ● ○ 
 SF3b50 ● ● 
 SF3b10 ● ● 
 SF3b14b ○ ○ 
U4/U6 snRNP hPrp4  ● 
U5 snRNP hPrp8 ●  
 U5-200  ● 
    
Splicing factors     
 PSF ○ ○ 
 p54nrb ○ ○ 
 YB-1 ●  
 SRm300 ○ ○ 
 TLS/FUS ○ ○ 
 FBP-2 ○ ○ 
core SR proteins ASF/SF2 ● ● 
 SRp20 ○  
 9G8 ● ● 
    
hnRNPs       
 hnRNP C1/C2 ● ● 
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Table 2, continued 
    
Category/function Protein name (-) pre-mRNA (+) pre-mRNA 
 hnRNP G ● ● 
 hnRNP H3 ● ● 
 hnRNP L ● ● 
 hnRNP M ● ● 
 hnRNP-homolog JKTBP ● ● 
 Similar to hnRNP A3 ● ● 
 type A/B hnRNP ● 
    
RNA unwindases     
 RH II/Gu ● ● 
 DDX9   ● 
 UAP56   ● 
 p72 ○ ○ 
    
Transcription factors     
 TF II D-70 ●  
 TIP49a   ● 
 TIP21   ● 
 mMED8   ● 
 ILF2/NF45 ●  
 TLE3   ● 
 FBP-3  ● 
 TDP-43 ●  
 TAT-SF1   ● 
 Pol III ●  
 Pol III C11 ●  
    
Other RNA processing factors   
mRNA-decay HuR ● ● 
export? NF90(ILF3) ● ● 
export Aly ○  
3’-processing CFIm, 25 kDa subunit ● ● 
 CFIm, 59 kDa subunit   ● 
snRNP SMN ●  
    
Ser/Thr kinases     
 CK II ●  
 CaMK-II beta subunit ●  
  STK9 ●   
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penta-snRNP.  Unfortunately, a variety of functional tests have proven intractable.  
Nevertheless, the discovery of a potential mammalian penta-snRNP and the intriguing 
possibility that it might represent a pre-formed spliceosome raises interesting questions 
for splicing regulation, especially control of alternative splicing. 
 
Discussion 
 
The PCC complex is a multi-snRNP complex. 
We have shown that the PCC complex, a PSF-containing multi-snRNP complex, 
forms in HeLa nuclear extracts under splicing conditions.  It has a size similar to that of 
the spliceosome, and contains all of the five splicing snRNPs as well as other non-snRNP 
splicing factors.  Both sucrose gradient sedimentation analysis and co-IP experiments 
using PSF-specific antibodies demonstrated that neither ATP nor exogenous pre-mRNA 
is required for formation of the complex.  Approximately 70 protein factors were 
identified as components of the PCC complex, and 70% of them are either known 
spliceosomal components or functionally related to splicing.  Though similar, the PCC 
complex is clearly different from fully-assembled/active spliceosomes in two ways.  
First, assembly of active spliceosomes requires ATP hydrolysis.  Second, many 
spliceosomal proteins, including cap binding proteins (CBP) and essential splicing factors 
such as U2AF65, second step factors Prp16, Prp17, and the recently characterized Prp19 
complex proteins (Ajuh et al., 2000), were not identified in the particle.  It is possible 
that some of these protein factors are lost during purification while others are not readily 
identified by mass spectrometry due to technical difficulties. 
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Spliceosomal complexes and the PCC 
During the past two decades, many splicing complexes and splicing related particles 
have been studied by several groups (reviewed in Jurica and Moore, 2003).  As 
discussed above, the presence of multiple snRNPs and the protein contents of the PCC 
complex make it distinct from other spliceosomal complexes (E, A, B, C complex, yeast 
Cwf/Cwc complexes, and the so called “super-spliceosome”, lnRNP; Hartmuth et al., 
2002; Jurica et al., 2002; Makarov et al., 2002; Michaud and Reed, 1991; Muller et al., 
1998; Ohi et al., 2002).  In 1988, Konarska and Sharp reported the formation of a 
pseudospliceosome complex in HeLa nuclear extracts in the absence of pre-mRNA 
(Konarska and Sharp, 1988).  This complex, which contains U2, U4, U5, and U6 
snRNPs, formed under high salt condition (250 mM salt), and was undetectable under the 
low salt conditions required for the PCC complex, thus, it is unlikely to be a part of the 
PCC complex.  The most comparable splicing related complex to the PCC complex 
would be the recently described yeast penta-snRNP (Stevens et al., 2002).  Both form 
under low salt conditions (50 mM NaCl for the penta-snRNP, and 60 mM KCl for the 
PCC complex) in the absence of pre-mRNA, contain all five splicing snRNPs, and lack 
some of the known spliceosomal protein factors.  However, the PCC complex also 
contains a large number of hnRNPs as well as other RNA processing factors involved in 
transcription, mRNA 3’ processing, and mRNA export, making it a distinct multi-snRNP 
complex. 
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Is the PCC complex functional? 
A key unanswered question is whether the PCC functions during splicing.  To 
address this, concentrated PCC complexes with high purity will be required for 
complementation experiments or direct functional analyses.  A variety of purification 
strategies have been used, unfortunately, none were able to answer the question for a 
variety of technical reasons.  First, complexes immunopurified using antibodies against 
either full length PSF or a short peptide were inefficiently immunoprecipitated and 
difficult to elute with PSF peptides (data not shown).  Second, unlike the yeast 
penta-snRNP, the PCC complex is not very stable, and starts to disassociate while 
re-sedimentating in sucrose (or glycerol), resulting in poor separation from smaller 
complexes (see Fig. 15 and data not shown).  Future work will be directed toward 
overcoming these obstacles to determine functionality.  However, even if successful, 
interpreting the implications of such experiments will still be challenging.  The 
composition of the PCC complex suggests it functions in pre-mRNA splicing but it is 
possible that it could also function in other nuclear events, consistent with proposed roles 
for PSF in a variety of pathways.  For any of these, loss of one or more essential factors 
could render the complex nonfunctional.  If supplied with soluble factors or other 
proteins fractions, for example, micrococcal nuclease (MN) treated nuclear extracts, 
functionality might or might not be restored depending on a variety of variables.  Even 
in case of restored functionality, there still exists a possibility that the complex might not 
function as an intact/pre-formed particle. 
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Does pre-assembly also exist in mammals? 
Three years ago, the discovery of the yeast penta-snRNP suggested that not all 
spliceosomes assemble de novo in a stepwise manner (Stevens et al., 2002).  The 
similarity between the PCC complex and the yeast penta-snRNP opens the possibility that 
mammalian penta-snRNPs or preformed-spliceosomes may also exist in mammalian cells.  
This is particularly interesting when considering alternative splicing.  The most 
straightforward models of splicing regulation posit that a variety of RNA elements and 
factors act combinatorially to precisely control splice site selection.  Should pre-formed 
spliceosomes exist, one could envision two classes of introns.  The first would be 
constitutively spliced introns with strong splicing signals and little cell- or tissue-specific 
regulation.  Such introns could be spliced using a largely pre-formed machinery.  In 
contrast, highly regulated splicing events might utilize a step-wise pathway allowing for 
precise control.  Considering the high frequency of alternative splicing events in 
mammalian cells, it is possible that both pathways exist. 
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CHAPTER IV 
 
SUMMARY AND CONCLUSIONS 
 
Pre-mRNA splicing is a delicate process involving multiple steps in spliceosome 
assembly and splice site choice followed by accurate joining of exons.  While many 
proteins have been identified as essential splicing factors, the exact functions of most of 
these factors are poorly understood.  Among these factors is PSF which has been 
identified as a spliceosomal protein under a variety of purification conditions (Chapter I, 
also see Table 1) and plays an important role in early spliceosome assembly and the 
second step of splicing (Gozani et al., 1994; Patton et al., 1993).  More recent evidence 
revealed its association with both the 5’ splice site (Kameoka et al., 2004) and the 
U4/U6.U5 tri-snRNP (Teigelkamp et al., 1997) but exactly where and when it functions 
during splicing remains unclear. 
Here, experiments were performed to better understand the RNA binding specificity 
of PSF and identify potential protein-protein interaction partners.  The finding that PSF 
is found within a large complex containing all 5 snRNPs raises the interesting question as 
to whether pre-formed spliceosomes exist in mammalian cells.  Such a finding would 
dramatically alter how spliceosome assembly is viewed, whether stepwise, largely 
pre-formed, or both.  Future functional experiments will be needed to address this 
interesting question along with precisely defining the role that PSF plays in splicing.  
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PSF and p54nrb Associate with U5 SnRNA during Splicing. 
 
PSF and p54nrb bind a conserved stem in U5 snRNA. 
The high degree of conservation of U5 stem 1b in vertebrates and flies (Fig. 9D) 
implies that it plays a critical role in U5 function.  Interestingly, we have demonstrated 
that PSF interacts with its highly related protein p54nrb and that both of these proteins, 
individually and in combination, select the same purine-rich sequence located on the 3’ 
side of U5 snRNA stem 1b as their optimal RNA binding sites (Chapter II).  Binding of 
PSF and p54nrb to U5 was first verified by gel shift assays, and then analyzed by filter 
binding assays as well as RNA affinity selection experiments.  Binding specificity for 
both proteins appears to depend on multiple elements, including the sequence and 
structure of stem 1b.  Furthermore, sedimentation analyses confirmed that both proteins 
associate with spliceosomes and with U4/U6.U5 tri-snPNP. 
Unlike higher eukaryotes, the PSF-p54nrb binding site is not present in the 
corresponding regions of yeast U5 snRNA (Fig. 9D).  This lack of conservation, 
together with the apparent absence of PSF and p54nrb homologs in yeast, suggests either 
that yeast U5 functions differently from that of higher eukaryotes, or that yeast contain an 
as yet unidentified functional homolog of PSF and p54nrb.  Nevertheless, this intriguing 
correlation indicates functional significance for the interaction between PSF-p54nrb and 
U5 snRNA in higher eukaryotes. 
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Model for PSF-p54nrb in potential U5 rearrangement 
Since double-stranded RNAs adopt the A-form conformation which precludes 
base-specific interaction with protein side chains in the deep major groove (Steitz, 1999), 
the question arises as to how PSF and p54nrb interact with an A-form helix while 
apparently maintaining sequence specificity.  Two ATPases (U5-100 kDa and U5-200 
kDa) and one homolog of EF-2 GTPase (U5-116 kDa) have been found to associate with 
U5 snRNP.  U5-100kDa and its yeast homolog Prp28 have been proposed to function in 
disassociation of U1 from the 5’ splice site (Chen et al., 2001; Staley and Guthrie, 1999), 
and U5-200kDa/Brr2 has been implicated to facilitate U4/U6 unwinding (Laggerbauer et 
al., 1998; Raghunathan and Guthrie, 1998).  Interestingly, IL2, the internal loop between 
stem 1b and 1c, is required for efficient association of hPrp8 and U5-116 kDa with U5 
(Hinz et al., 1996; Ségault et al., 1999), while hPrp8 forms a stable complex with 
U5-200kDa, U5-116kDa, and U5-40kDa (Achsel et al., 1998).  Given the proximity 
between stem 1b and at least two putative RNA unwindases (U5-100 and U5-200), it 
seems reasonable to propose that stem 1b of U5 might also undergo a conformational 
change during spliceosome assembly or during the two catalytic steps.  Therefore, we 
speculate that PSF and p54nrb could bind U5 in two ways: to the intact stem, or to the 3’ 
side of the stem after melting. 
As to how PSF and p54nrb might function in this process, there are at least two 
possibilities (Fig. 19).  First, PSF and p54nrb may initially bind to double stranded stem 
1b but then bind more tightly to the 3’ side of the stem upon unwinding.  Such binding 
could stabilize the unpaired strands coincident with U4/U6.U5 tri-snRNP contacting the 
5’ splice site, or perhaps during the second step of splicing.  Second, given that PSF has 
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Figure 19.  Model for PSF-p54nrb in potential U5 rearrangement.  During the 
spliceosome assembly or during the transition from the first catalytic step to the second 
step of splicing, association of PSF-p54nrb with U5 snRNA may affect U5 structure in 
two possible ways.  As shown in clockwise, after PSF-p54nrb binds the double-stranded 
stem 1b of U5 snRNA, other protein factors associated with U5 (such as an RNA 
unwindase) unwind stem 1b.  PSF-p54nrb now binds the 3’ side of the stem and helps to 
stabilize the opened U5 structure.  Later disassociation of PSF-p54nrb from U5 results in 
reconstruction of the original stem structure.  Or, as shown in counter clockwise, stem 
1b is first unwound by other protein factors such as an RNA unwindase associated with 
U5, while binding of PSF-p54nrb to the 3’ side of the stem induces reconstruction of the 
double-stranded stem.  PSF-p54nrb then disassociates, leaving U5 ready for next round 
of splicing. 
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been demonstrated to promote the annealing of DNA (Akhmedov and Lopez, 2000), PSF 
and p54nrb could facilitate the reannealing of U5 stem 1b subsequent to melting, mediated 
by one or more unwindases.  Either way, the interaction could be transient, supported by 
non-stoichiometric association of PSF with the U4/U6.U5 tri-snRNP (Teigelkamp et al., 
1997) and the fact that only a small amount of PSF and p54nrb co-sediments with 
U4/U6.U5 tri-snRNP and with splicing complexes (Chapter II, Fig. 13).   
 
PSF as a Part of a Mammalian Multi-snRNP Complex 
During our studies of PSF/U5 interactions, we discovered the PCC, a 
PSF-containing multi-snRNP complex in HeLa nuclear extracts adjusted to splicing 
conditions.  The PCC contains all of the five splicing snRNPs and has a size similar to 
that of the spliceosome.  Approximately 70 protein factors were identified as 
components of the PCC complex and 70% of them are either known spliceosomal 
components or functionally related to splicing (see Chapter III).  
 
The PCC is a distinct multi-snRNP complex. 
Both the presence of multiple snRNPs and the protein contents of the PCC make it 
distinct from other in vitro assembled spliceosomal complexes (E, A, B, C complex) and 
the endogenous Cwf/Cwc complexes from yeast (reviewed in Jurica and Moore, 2003) 
(compare Table 2 with Table 1).  In addition, the low salt resistance of the PCC (100 
mM KCl) suggests that it might not be related to the pseudospliceosome complex 
detected in HeLa nuclear extracts which contains U2, U4, U5, and U6 snRNPs but forms 
only under high salt conditions (250 mM salt; Konarska and Sharp, 1988).  Furthermore, 
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the PCC is apparently different from fully-assembled or active endogenous spliceosomes 
in two ways.  First, assembly of active spliceosomes requires ATP hydrolysis whereas 
neither ATP nor exogenous pre-mRNA is required for the formation of the PCC.  
Second, many spliceosomal proteins, including cap binding proteins (CBP) and essential 
splicing factors such as U2AF65, second step factors Prp16, Prp17, and the recently 
characterized Prp19 complex proteins, were not identified in the PCC. 
The most comparable splicing related complex to the PCC would be the recently 
described yeast penta-snRNP (Stevens et al., 2002).  Though different in that the PCC 
contains a large number of hnRNPs and other RNA processing factors involved in 
transcription, mRNA 3’-processing, and mRNA export, these two complexes clearly 
resemble each other in several ways.  Both form under low salt conditions (50 mM NaCl 
for the penta-snRNP, and 60 mM KCl for the PCC complex) in the absence of 
pre-mRNA, contain all five splicing snRNPs, and lack several known spliceosomal 
protein factors. 
 
Does pre-assembly also exist in mammals? 
Given the similarity between the PCC and the yeast penta-snRNP, the discovery of 
which suggested that not all spliceosomes assemble de novo in a stepwise manner 
(Stevens et al., 2002), it is possible that mammalian penta-snRNPs or 
preformed-spliceosomes may also exist in mammalian cells.  This is particularly 
interesting when considering alternative splicing.  The most straightforward models of 
splicing regulation posit that a variety of RNA elements and factors act combinatorially 
to precisely control splice site selection.  Should pre-formed spliceosomes exist, one 
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could envision two classes of introns.  The first would be constitutively spliced introns 
with strong splicing signals and little cell- or tissue-specific regulation.  Such introns 
could be spliced using a largely pre-formed machinery for efficient splicing.  In contrast, 
highly regulated splicing events might utilize a step-wise pathway or a semi-pre-formed 
pathway allowing for precise control and multiple steps along the pathway.  In the 
semi-pre-formed model originally proposed by Abelson and colleagues, U1 snRNP first 
recognizes the 5’ splice site after which the U2/U4/U6/U5 tetra-snRNP is recruited to the 
branch point/3’ splice site (Stevens et al., 2002).  In the eukaryotic system, one can 
imagine splice site choice being regulated in a similar manner (Fig. 20).  Considering 
the high frequency of alternative splicing events in mammalian cells, it is possible that 
both pathways exist.  In support of this, mammalian complexes resembling both the 
yeast penta- and tetra- snRNPs have been discovered: the PCC complex and the 
U2/U4/U6/U5 pseudospliceosome complex by Konarska and Sharp (Konarska and Sharp, 
1988), respectively.  Unfortunately, neither has been proven functional in splicing so 
future work will be required to address this challenging but fascinating hypothesis. 
 
A PSF coupled network? 
Other than its role in pre-mRNA splicing, PSF has been proposed to function in 
multiple nuclear events including transcription, and mRNA retention/export, two 
processes known to be coupled to splicing (Reed, 2003; also see Chapter I).  
Interestingly, besides snRNPs and splicing factors, protein factors involved in 
transcription, 3’-processing, and mRNA export were also identified in the PCC, such as 
TAT-SF1, which has been demonstrated to couple transcription and splicing, and  
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Figure 20.  Model for potential penta-snRNP and tetra-snRNP in mammalian 
pre-mRNA splicing.  (A) Constitutively spliced introns are recognized by 
penta-snRNPs in a pre-formed manner.  (B) One example of how tetra-snRNPs may 
function in cell- or tissue-specific regulation of alternative splicing.  5’ and 3’ splice 
sites are recognized by U1 snRNP and tetra-snRNP, respectively.  Splice site choice is 
therefore regulated by different sets of splicing factors that bridge U1 with tetra-snRNPs. 
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Aly/REF, a component of the EJC complex that couples splicing to NMD and mRNA 
export (Chapter I and III).  Does the PCC simply represent those coupled nuclear 
machineries described above?  Or does PSF serve to link the various processes in some 
way?  We do not have an answer as yet, but at least two more lines of evidence suggest 
that PSF might be involved in coupling transcription and splicing.  First, PSF and p54nrb 
were found in a large mammalian transcription/splicing complex (Kameoka et al., 2004) 
similar to the yeast TREX complex (Strasser et al., 2002).  Second, both PSF and p54nrb 
were shown to interact with the CTD of RNA Pol II (Emili et al., 2002), an important 
player in coupling transcription and splicing. 
As to the potential role(s) of PSF in this process, it is possible that PSF might 
function like TAT-SF1, which serves as a transcription coregulator and recruits splicing 
factors to the nascent pre-mRNA (Fong and Zhou, 2001).  Given the fact that PSF 
interacts with both the 5’ splice site (Kameoka et al., 2004) and U1A (Lutz et al., 1998), 
it may directly contact the 5’ splice site and/or help recruit U1 after transcription 
initiation through its interaction with Pol II CTD thereby bringing splice sites into the 
proximity of splicing factors associated with Pol II CTD. 
In summary, this work has demonstrated that PSF interacts with its highly related 
protein p54nrb and that both bind the conserved stem 1b of U5 snRNA.  The interaction 
between U5 and PSF-p54nrb is critical for U5 function and might promote or stabilize 
possible U5 conformational rearrangements during splicing.  Furthermore, we have 
identified the PCC, a PSF-containing multi-snRNP that resembles the yeast penta-snRNP.  
These data provide evidence for PSF function in pre-mRNA splicing and suggest 
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potential links between transcription and splicing although much more work will be 
needed to test these intriguing hypotheses. 
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